Hospital Resource Guide - Memorial Blood Centers

Transcription

Memorial Blood Centers Hospital Resource Guide
Memorial Blood Centers
A Division of Innovative Blood Resources
We create trusted and innovative solutions to help our customers achieve their goals
Table of Contents
Introduction1
About this Hospital Resource Guide
1
About Memorial Blood Centers, A Division of Innovative Blood Resources
Who We Serve
How We Do What We Do
2
3
4
Updates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
We invite your comments. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Right Production, Right Type . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
A Service Culture Designed to Meet all of your Hospital’s Needs
We’re Here When You Need Us
By Phone . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
On the Web . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
Routine Ordering and Delivery
5
6
7
Routine Orders
STAT and ASAP Orders
7
7
Ordering Policy
Supply Orders
Routine Ordering and Delivery Times
7
7
7
Ordering Special Components
8
Transportation of Blood Components
9
Definitions:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Saint Paul . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Duluth . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
Modified Components. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
Memorial Blood Centers-Central (MBCM). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
Memorial Blood Centers-Duluth (MBCD) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
Delivery Services . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Blood Hub Use
Blood Hub Screen Examples
Routine Order Form
12
12, 13
14
Handling, Storage and Return
15
Handling and Storage of Blood Components
Receiving Blood and Components . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Packing Lists . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
Manual Packaging List. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Blood Component Return Guidelines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
15
Guidelines for Storage of Blood and Blood Components
18, 19
Transferring Units
19, 20
Memorial Blood Centers Policy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Example Record of Return/Transfer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Transferring Units to Another Memorial Blood Centers Facility. . . . . . . . . . . . . . . . . . . . . . . 19
Transferring Units with a Patient to:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Hospitals Memorial Blood Centers Does Not Service. . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Inventory Reconciliation
20
Guidelines for Returning and Packing of Red Blood Cells
20
Guidelines for Packing Platelets
20
Shipping Box. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
Rev. June 2015
MBC.ORG ©2015 Memorial Blood Centers. Confidential and Proprietary. All rights reserved.
Table of Contents • Page ii
Product Codes
22
Memorial Blood Centers Transfusable Blood Product Codes Manufactured at MBC
Whole Blood. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Frozen RBC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Non-Leukoreduced RBC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23–24
Leukoreduced RBC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24-27
Apheresis Platelets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27-28
Platelet from Whole Blood. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Pooled Platelets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29
Plasma. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29-30
Memorial Blood Centers Testing Catalog
22
31
Donor Testing Laboratory
Viral Screening, Red Cell Typing, Nucleic Acid Testing. . . . . . . . . . . . . . . . . . . . . . . . . 31–39
Quality Assurance
31
41
Physician Services and Quality and Regulatory Affairs
Quarantine, Market Withdrawal, Recall, Inventory Lookback and Recipient Notification
41
41
Reporting Adverse Outcomes of Transfusion
Communications
41
42
Quality Control (QC) of Blood Components
43
If you are notified of a market withdrawal or recall, it is imperative that you: . . . . . . . . . . . . . . . . 41
Customer Service Reports:. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Serious Outcome of Transfusion Report. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Suspected Transfusion Transmitted Disease Report. . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Reference Laboratory
45
Request for Antibody Identification and Red Cell Crossmatching
Unit Antigen Typing
Antibodies in Donors
Platelet Crossmatching
HLA Matched Platelets
Service Fees
Request for Reference Lab Testing
Guidance for Industry
Qualifications Letter
45
45
45
45
46
46
47
48-54
55
Memorandum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
Parentage Testing
Common Questions & Answers
56
Why should you choose Memorial Blood Centers?. . . . . . . . . . . . . . . . . . . . . . . . . . . . .
How can I start testing for a parentage dispute?. . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
What type of testing is available? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
At what age are children able to be tested? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
What type of sample is collected from the individuals tested? . . . . . . . . . . . . . . . . . . . . . . .
How long does the collection take? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Is there a difference in accuracy between a blood and buccal swab sample?. . . . . . . . . . . . . . .
Are these tests accurate? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
How long will it take to get results? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Will the child and/or mother need to be re-collected if the first man is excluded? . . . . . . . . . . . . .
Can tests be performed when the parties involved live in different states or countries?. . . . . . . . . .
If an Alleged Father is deceased can paternity testing still be done?. . . . . . . . . . . . . . . . . . . .
Is the accuracy of a DNA test affected by drug use, illness or disease?. . . . . . . . . . . . . . . . . .
Parentage Testing Services
56
56
56
56
56
56
57
57
57
57
57
57
57
Service Fees. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
Rev. June 2015
56
58
Table of Contents • Page iii
Routine Trios (Mother, Child & Alleged Father). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Family Studies (Motherless, Fatherless, Grandparents, Siblings, Y-chromosome, etc.). . . . . . . . . . .
Special Testing. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Additional Fees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Expert Witness . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Educational Opportunities
Department of Training and Education. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
American Association of Blood Banks (AABB) Audioconferences/
American Society for Clinical Pathology (ASCP) Teleconferences . . . . . . . . . . . . . . . . . . . . .
Student Rotations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Facility Tours. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Volunteer Opportunities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Continuing Education. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Current Topics and Controversies in Transfusion Medicine. . . . . . . . . . . . . . . . . . . . . . . . .
Reference Laboratory Workshops. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
School Presentations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
“My Blood, Your Blood” . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Technical Advisory Meeting (TAM). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Medical Advisory Council. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Testing Services
Thank You
Addendum 58
58
58
58
58
59
59
59
59
59
59
59
59
60
60
60
60
Special Collections . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 64
Rev. June 2015
59
61
63
64
Table of Contents • Page iv
Introduction
About this Hospital Resource Guide
Overview
We invite your comments.
Memorial Blood Centers is honored to be your
healthcare partner. And we are committed to ensuring
that you have the resources you need to perform at
your best as you provide the essential services that
save and sustain lives. This Hospital Resource Guide,
provided exclusively to our valued hospital partners,
has been created to help streamline the delivery of our
services to you and most effectively support you in
your work. It is an important reference that details our
operating policies, procedures, and practices.
Memorial Blood Centers strives to provide you with
the best customer service possible and we welcome
your thoughts and ideas about this Hospital Resource
Guide. If there is important information you would
like to see included or other ways we can effectively
keep you up-to-date on operational changes, please
feel free to contact us at 651-332-7108 (Metro) or 218740-1520 (Northland).
Please keep this resource guide in a convenient place
and use it as an easy-to-access tool to help answer
questions you might have. Additional information
also can be quickly accessed at our website: MBC.
ORG/Products-and-Testing-Services. In addition,
feel free to contact Hospital Services for more
information at 651-332-7108 (Metro) or 218-740-1520
(Northland).
This Hospital Resource Guide is provided for the
exclusive use of Memorial Blood Centers’ hospital
partners. Any other distribution or use is strictly
prohibited.
Updates
From time to time, the information contained in
this Hospital Resource Guide may change or become
outdated. When appropriate, Memorial Blood
Centers will issue updates. Please be aware that it is
the hospital’s responsibility to ensure it has the most
current information and that the updated pages or
sections are added and old pages are discarded.
If you are unsure if this guide contains the most
current updates, please call Hospital Services for
clarification or visit our website at MBC.ORG.
Rev. June 2015
Introduction • Page 1
About Memorial Blood
Centers, A Division of
Innovative Blood Resources
Who we are
Memorial Blood Centers has been saving and
sustaining lives for over 65 years. A Minnesota-based,
independent nonprofit, we supply life-saving blood,
state-of-the-art laboratory services, and biomedical
expertise to area hospital and clinic partners, national
blood centers, biotechnology companies, research
institutions, and international clients from Australia
to Switzerland.
As a mission-driven organization committed to
advancing the cause of blood donation and ensuring
the health and well-being of all of our citizens, in 2012
Memorial Blood Centers formalized a decade-long
partnership with Nebraska Community Blood Bank
(NCBB) of Lincoln, NE to form a new blood services
organization. Our two community-based non-profits
now operate as divisions of the newly formed entity:
Innovative Blood Resources. Both are 501(c)(3) notfor-profit, charitable organizations. Each is licensed by
the FDA and accredited by AABB and CLIA.
While we will continue doing business as (d/b/a)
Memorial Blood Centers, all blood products collected
by MBC and NCBB and shipped to our hospital
partners will be labeled with the Innovative Blood
Resources name.
Learn more about:
Innovative Blood Resources at InnovativeBloodResources.org
Memorial Blood Centers at MBC.ORG
Nebraska Community Blood Bank at NCBB.ORG
Mission | To help save lives by providing blood and biomedical services
Rev. June 2015
Who We Serve
As a division of Innovative Blood Resources,
Memorial Blood Centers provides a comprehensive
menu of blood products, laboratory services, and
technical expertise to a diverse client base of over
40 partner hospitals in Minnesota, Nebraska and
Wisconsin—from large, multi-unit systems to
government-run Level 1 trauma centers, to tertiary
hospitals and rural facilities. Additionally, we serve
dozens of laboratory and blood bank customers across
the United States, including the Mayo Clinic and the
National Marrow Donor Program (Be The Match),
and provide blood products for special manufacturing
around the globe.
As a national blood provider with a local focus on
community participation to advance our mission
of saving lives through blood donation, we service
customers with core competencies in production
planning, blood utilization management, advanced
Immunohematology Reference Laboratory services,
and internationally-recognized transfusion medicine
expertise. Visit our website at MBC.ORG/About-Us/
Service-Area for a current list of hospital partners.
Blood Products
Reference Lab
Donor Testing
International
Vision | To delight our customers and be the best blood center in America
Rev. June 2015
How We Do What We Do
With hospitals as our most valuable partners, our
work at Memorial Blood Centers comes full circle:
from donor to recipient.
Our core work processes connect people to people.
Beginning with generous donors, Memorial Blood
Centers’ systematic, robust processes help us achieve
our ultimate goal: meeting patients’ needs 100% of
the time by delivering the life-saving blood to our
hospital partners that recipients need whenever,
wherever it is needed most.
A two-time Minnesota Quality Award winner
recognized for our commitment to continuous
improvement and customer service, Memorial
Blood Centers maintains safety and quality at the
highest levels possible while streamlining processes
and maximizing cost-efficiencies to deliver
competitively-priced blood products.
Right production, right type—
readily available at the right time
Sophisticated production planning, effective
screening and manufacturing, excellent forecasting,
and deployment of leading-edge technology ensure
that Memorial Blood Centers efficiently meets each
hospital’s unique specifications. As a result, we have
built a solid reputation for dependability, reliability,
and service excellence with local, regional, and
national clients.
Donors
Production
Planning
Manufacturing
Collections
Recruitment
Testing
Recipients
Distribution
Strategic Approach | We create trusted and innovative solutions to help customers
achieve their goals
Rev. June 2015
A service culture
designed to meet all of
your hospital’s needs
With a 65-year legacy of serving the needs of hospitals
large and small, CAH and PPS partners alike,
Memorial Blood Centers has become the Partner-ofChoice for hospitals that demand:
• reliable availability and 24/7 convenience
• easy online ordering and comprehensive testing
services
• transfusion support for cost-effective blood
management
• in-service training programs for hospital staff
• flexibility, agility, and creative solutions to meet
unique requirements
In addition to providing a comprehensive menu
of blood products, Memorial Blood Centers is a
nationally-recognized leader in advanced laboratory
testing. Our FDA-licensed and EU-compliant
advanced laboratory facilities provide a full range of
testing services to help ensure a safe and stable blood
supply that protects donors and recipients, while
research advances the scientific study of infectious
diseases that set the standard for the blood industry.
• Decades of experience performing more than 3
million blood sample tests for clients, including
reproductive medicine providers, national and
regional blood centers, the National Marrow Donor
Program, and such world-renowned facilities as the
Mayo Clinic
• AABB-accredited Immunohematology Reference
Laboratory
• HPC-Hematopoietic Progenitor Cell Lab
accredited by AABB and The Foundation for the
Accreditation of Cellular Therapy (FACT)
• Partner of the American Rare Donor Program
FDA registered | AABB Accredited | CLIA Licensed
Visit MBC.ORG/About-Us/Accreditations
to view all current accreditations.
Rev. June 2015
We’re here when you need us
By Phone:
On the Web:
MBC.ORG/Products-and-Testing-Services/
Products-and-Testing-Services-Overview
Key Contacts - Metro
General Information
1-888-GIVE-BLD
(888-448-3253)
651-332-7000
Hospital Services
651-332-7108 Phone
651-332-7004 Fax
651-490-9431 Cell
Hospital Services & Lab Relations
Manager
651-332-7109
Key Contacts - Northland
General Information
218-723-8080
Duluth Hospital Services
218-740-1520 Phone
218-740-1521 Fax
218-591-3813 Cell
Component Services Manager
218-740-6125
Additional Contact Information
Billing/Invoice Questions
Accounts Receivable
651-332-7252
Donor & Patient Testing
651-332-7119
Reference Laboratories
651-332-7125
Associate Medical Director
and Director, Physician Services
Elizabeth Perry, M.D.
651-332-7285
Medical Director and VP, Medical &
Regulatory Affairs
Jed Gorlin, M.D.
651-332-7284
Rev. June 2015
Routine Ordering and Delivery
Routine Orders
Ordering Policy
Routine orders for blood and/or components are made
by accessing the Memorial Blood Centers website
www.mbc.org and logging into the Blood Hub Online
Ordering System. Each Transfusion Services employee
will be entered into the Blood Hub system by the
Memorial Blood Centers Hospital Services Designee
or the Transfusion Services assigned administrator for
your facility. Blood Hub will send the user an email
with a link to set their own password. Passwords are
required to be changed every 90 days. (See example of
login screen on page 12.)
Full-Service Hospitals recognize that Memorial Blood
Centers is the primary source for blood and blood
components. Specifically, Memorial Blood Centers
maintains a sufficient inventory to meet hospital
needs. In the event that Memorial Blood Centers
does not have sufficient inventory, Memorial Blood
Centers will contact other blood centers to obtain the
blood and blood components needed. If Memorial
Blood Centers cannot meet the hospital’s need within
the time frame requested, the hospital may contact
another blood center or non-affiliated hospitals to
obtain the required blood and/or blood components.
As a back-up to the Blood Hub Online Ordering
System, Memorial Blood Centers will provide a paper
copy of the Fax Order Form. The Fax Order Form
should be used only when the Blood Hub System is
not functioning. (See example on page 14.)
For technical difficulties with Blood Hub, we request
that you contact a Memorial Blood Centers Hospital
Services Designee or the Transfusion Services
assigned administrator for your facility.
For reasons of inventory management, Memorial
Blood Centers reserves the right to ship ABO
compatible components in lieu of the specific
requested type. If Memorial Blood Centers requests
that a substitution be made, the charge will reflect the
component of lesser cost.
STAT and ASAP Orders
The Hospital Services Department is staffed 24
hours, 7 days a week at the Saint Paul location and
the Duluth location. To place a STAT/ASAP order,
log on to Blood Hub and place your order. All STAT
and ASAP phone orders must be followed-up with a
submitted order through Blood Hub or via fax.
Definitions:
• STAT — Orders are for an emergency need,
shipped in 1 hour once the component is available.
• ASAP — Orders are shipped in less than 4 hours
once the component is available.
• Routine — Orders are sent with the next scheduled
delivery to your facility, or in less than 24 hours.
• Specialty Orders — Reference Lab requests can be
placed through Blood Hub.
• Memorial Blood Centers-Central (MBCM)
• Memorial Blood Centers-Duluth (MBCD)
Supply Orders
Supplies can be ordered through Blood Hub or the
fax order form if Blood Hub is not functioning. For a
complete listing of supplies available from Memorial
Blood Centers, refer to the current service fees.
Routine Ordering and
Delivery Times
Saint Paul
Day
Order Time
Delivery Time
Monday – Friday
Morning Orders
6:30 am to 8 am
9 am to 10:30 am
8 am to 9 am
10:30 am to Noon
Monday – Friday
Afternoon Orders
2 pm to 4 pm
4:30 pm to 7:30 pm
Saturday and Sunday
By 9 am
9:30 am to 1 pm
Day
Order Time
Delivery Time
Monday – Friday
7:00 am to 9 am
10 am to 11:30 am
Duluth
Stock Rotation for Duluth Facilities
Stock rotation occurs every 1–3 weeks for some affiliate sites on
predetermined dates. The hospital rotates older stock units back to
Memorial Blood Centers-Duluth in return for fresher units.
note: Duluth area hospitals located out of town
that are served by Memorial Blood Centers should
communicate with the Duluth Hospital Services staff
when ordering blood/components that are not part of
their routine exchange. These orders should be placed
early enough for Memorial Blood Centers to arrange a
routed courier service. Please contact Duluth Hospital
Services for delivery time frame.
Rev. June 2015
Routine Ordering and Delivery • Page 7
Ordering Special Components
Modified Components
To order modified components place the order using
Blood Hub or the Fax Order Form can be used when
Blood Hub is not functioning. Because modification
of blood components can be a time consuming
process for the blood center, please consider this
when placing the order to ensure timely delivery.
The expiration date for most modified components
is shortened, which must also be considered prior
to placing an order. Refer to the table below for
approximate modification times and new expiration
dates.
Special Component Requests
Component
Description
*Approximate
Preparation Time
New Expiration
Date
Availability
Washed Red Cell Unit
(MBCM only)
1.5 hours
24 hours
M – F, 7 am –10 pm
Other times: on call charges apply
Deglycerolized Red Cell Unit
(MBCM only)
2 hours
24 hours
M – F, 7 am –10 pm
Washed Platelet Component
(MBCM only)
2.5 hours
4 hours
M – F, 7 am –10 pm
Irradiation of Components
15 minutes
28 days or unit expiration
(whichever
is shorter)
24 hours a day, 7 days a week
Volume Reduction of Platelets
1 hour
4 hours
M – F, 7 am –10 pm
If unit must be pooled prior to volume
reduction — add 30 minutes
Sterile Connection of Pediatric/
Transfer Bags
30 minutes
NA
M – F, 7 am –10 pm
Add 30 minutes if requesting Memorial Blood
Center to divide into transfer bags
Antigen Negative Unit
Dependent upon antigen
requested and inventory levels
NA
Refer to Reference Laboratory section
Preparation time does not include transportation
time to the hospital.
For requests during non-routine hours an additional
one hour must be added to preparation time. Call
Hospital Services to inquire about preparation times
for any components not listed above.
Rev. June 2015
Transportation of
Blood Components
• Memorial Blood Centers works together with each
hospital to select an appropriate delivery schedule
to meet the Hospital’s inventory needs.
• Memorial Blood Centers provides routine
deliveries at no charge according to an established
schedule.
• Charges for additional deliveries, requested by the
Transfusion Services, are the responsibility of the
requesting Hospital.
Memorial Blood Centers-Central
(MBCM)
Serving the Twin Cities Metro Area and Southern
Minnesota
Telephone number:
Cell number:
Fax number:
Hours of Operation:
Orders
Routine
Request
Restocking
Online ordering – see “Ordering Section”
for current schedule cut-off
Inventory Exchange
Standing Order
Non-Routine
NOTE: Orders not received by the cutoff will be shipped with the next
scheduled routine delivery. If needed earlier, the delivery charges are
the responsibility of the requesting Hospital.
Delivery Schedule
Central Business Hours:
24 hours a day, 7 days a week
Call MBCM Hospital Services and place order through
Blood Hub, the online ordering system.
Monday – Friday
2 deliveries daily
Saturday, Sunday, and
Holidays
1 delivery daily
STAT — Request processed immediately shipped <1
hour once product is available
Every 1–3 weeks as scheduled
ASAP — Request shipped < 4 hours once product
is available
Inventory Exchange
Delivery Charge
651-332-7108
612-490-9431
651-332-7004
24 hours a day
No Charge
Requesting facility pays delivery fees.
Transportation fees are billed monthly by MBC
Highway Patrol: The highway patrol is available
ONLY for Critical Medical Emergency transport.
The order MUST be ready for pick-up when
the Highway Patrol arrives at the sending
site — communication and coordination between
the sender and the receiver is crucial.
Rev. June 2015
Transportation of
Blood Components (continued)
Memorial Blood Centers-Duluth (MBCD)
Serving Duluth, Northern Minnesota and Wisconsin
Telephone number:
218-740-1520
Cell number:
218-591-3813
Fax number:
218-740-1521
Hours of Operation:24 hours a day
Orders
Routine
Non-Routine
Request
Restocking
Online ordering by 7:30 am. Our
earliest courier leaves at 8:00 am.
Inventory Exchange
NOTE: Orders not received by the cutoff will be shipped
with the next scheduled routine delivery. If needed earlier,
the delivery charges are the responsibility of the requesting
Hospital.
Delivery Schedule
Delivery Charge
Duluth Business Hours: 24 hours a day, 7 days a
week
Call MBCD Hospital Services or place order through Blood
Hub.
Monday – Friday
1 delivery daily
STAT — Request processed immediately shipped <1 hour
once product is available
Inventory Exchange
ASAP — Request shipped < 4 hours once product
is available
No Charge
Requesting facility pays delivery fees.
Transportation fees are billed monthly by MBC
Highway Patrol: The highway patrol is available
ONLY for Critical Medical Emergency transport.
The order MUST be ready for pick-up when
the Highway Patrol arrives at the sending
site — communication and coordination between
the sender and the receiver is crucial.
Rev. June 2015
Delivery Services
Carrier
Telephone #
Service Area
Service
Memorial Blood Centers -Central
651-332-7108
Twin Cities Metro Area, Southern/
Northern Minnesota
• Routine
• ASAP
• STAT
Memorial Blood Centers - Duluth
218-740-1520
Duluth, Northern Minnesota and
Wisconsin
• Routine
• ASAP
• STAT
Hybrid
612-308-7667
Twin Cities and Duluth
• Routine
• ASAP
• STAT
• Scheduled
Quicksilver
651-484-1111
Twin Cities
• Routine
• ASAP
• STAT
MedStat
763-586-0369
Twin Cities
• Routine
• ASAP
• STAT
Velocity Express
218-726-1514
Duluth Area
• ASAP
• STAT
Scheduled Routes in Duluth Region
ZOOM
218-348-1144
Duluth Area
• Routine
• ASAP
• STAT
• Scheduled
Northern Lights
218-729-5841
Duluth Area
Scheduled Routes in Duluth Region
Red & White
612-871-1600
Twin Cities
• Routine
• ASAP
• STAT
Allied
218-722-3311
Duluth Area
• ASAP
• STAT
Couriers
Cab
Orders must be placed with a minimum of 2 hours prior to published departure times
Other
Greyhound
Statewide
Call MBC-Central for schedule
Delta
United States
Midnight Express
United States
Skyline
skylineshuttle.com
Shuttle from Duluth to St. Paul and airport
Call MBC-Duluth
Fed-Ex
United States
Place order before 4 pm for next day
delivery. Sat. delivery available
Rev. June 2015
Blood Hub Use
See Blood Hub training presentation and Blood Hub
How to Guide links on the Blood Hub Dashboard
page for full instructions for use.
Example of the Blood Hub Log in Screen
Select the Products you are ordering, blood types, and
quantities
Verify that your order is correct
Complete your order
Rev. June 2015
Example for placing an antigen screened order
Note: An Antigen Screened order includes units that
will be tagged and have antigens confirmed
Note: Do not select Antigen Screened to request
“Historical” typed antigens – place a regular order for
those and type “Historical” in the comment field
Click the Create Order Link, select Antigen Screened,
and Shipping Options
Blood Hub allows you to place an order and tell us the
Date/Time when the order is needed. Select Delivered
by Date/Time under shipping options to use this
feature.
Select Products, Blood Types, and Quantities. Then
select the antigens to screen for
Verify the order for accuracy
Complete the Order
Rev. June 2015
Rev. June 2015
Handling, Storage and Return
Handling and Storage of
Blood Components
Receiving Blood and Components
Upon receipt of a shipment of blood and/or blood
components it is imperative that the receiving facility:
1. Ensure the blood and/or blood components have
arrived at your facility at the proper temperature:
ProductShipping Temperature
• Red Blood Cells 1 – 10o C
• Platelets
20 – 24o C +/-2o C
• Frozen Components Dry ice must be present
2. Compare the unit numbers and components on the
packing list against the actual numbers/components
received.
3. Visually inspect each unit received according to
your hospital policies and American Association of
Blood Banks (AABB) guidelines.
Packing Lists
Your facility will receive a packing list with each
shipment of blood and/or blood components. The
packing list contains a listing of each component
contained within the shipment. There is also a listing
of historical antigen typing for each red cell unit (refer
to Page 45 for a description of antigen testing). The
person at your facility who receives the shipment
should sign the packing list. Signed packing lists
should be maintained at your facility in accordance
with AABB and Food and Drug Administration
(FDA) guidelines.
In the event that the computer system at Memorial
Blood Centers is not functional and/or a component
must be sent to your facility as an emergency release,
you will receive a handwritten manual packing list.
The manual packing list must be treated as your
official packing list (as in the paragraph above).
Examples of a computer-generated and a manual
packing list are provided below and on the following
page.
note: Contact Hospital Services
immediately if a discrepancy or
problem is noted. If not contacted
in writing within 10 days of receipt
of shipment, your facility assumes
responsibility for each component
listed on the original packing list.
Rev. June 2015
Handling, Storage and Return • Page 15
Rev. June 2015
Blood Component Return Guidelines
These guidelines were developed to:
• Encourage judicious inventory management
practices by Memorial Blood Centers and each
of our customers for the benefit of all customers
served.
• Allow hospitals to establish their own criteria for
managing their unique patient populations and
sharing in the cost of meeting their inventory needs
Any component issued by Memorial Blood Centers
with a ‘shorted-dated’ sticker will not be charged
to the hospital if the unit outdates at the hospital.
Discard unit, report disposition and request credit on
Hospital Request Credit Report (Form-IT-005). Send
Hospital Request Credit Report to your distribution
hub by the last day of the month. Credit requests
received late will be posted to the next month’s
billing cycle. Policies/Guidelines are monitored for
effectiveness in inventory management and financial
outcomes; changes are made as necessary.
Modified components (washed, irradiated, volume
reduced, etc.) are not acceptable for return and credit
will not be issued with the exception of Irradiated Red
Cell Components. Irradiated Red Cells are acceptable
for return if they meet the guidelines listed below.
JobAid-HS-002.9 05/13
Rev. June 2015
Component
Guidelines
for Storage of
Platelet Apheresis — Reserved for a specific patient (by hospital
Blood
and Blood Components
request — yellow sticker):
Memorial Blood Centers Policy
HLA-Matched
All
full-service hospitals served by Memorial Blood
Special Typing
Centers
may(PIA1)
return blood components with an
Cross-matched
accompanying Record of Return Transfer form The
return form must be generated in Blood Hub or the
facilities own computer system (if the computer
system generates a pre-approved return packing slip)..
Units
acceptable for reissue will be charged to the
Plateletnot
Concentrates
hospital unless previous arrangements for credit have
been made. The following conditions apply to any
Frozen Plasma
Components
hospital
returning
blood components to Memorial
Blood Centers:
• The hospital must store all blood and blood
Components
not available
at Memorial
Blood Centers
components
according
to current
AABB and FDA
guidelines
• A Record of Return Transfer packing slip generated
by Blood Hub (see the example below) or the
Hospitals computer system must be included
with each return shipment. If Blood hub is not
Guidelines
functioning a Record of Return/Transfer paper
Sent to hospital
available
copywhen
(Form-HS-020)
(See example on page 19)
may be used as long as it is completely filled out.
Charged toEach
hospitalunit
if notreturned
used
must be listed on the return
form individually with a return reason clearly
If used by alternate hospital — collection fee of $250 plus special fees (HLA,
documented.
cross-matching, irradiation), charged to requesting hospital; receiving hospital
•
The Record of Return Transfer form MUST
charged $250
be completed by an employee of the hospital
Transfusion
thatspecific
the blood
All fees associated
with unitsService
importedto
to indicate
meet a patient’s
need are
blood components have been stored
passed on and/or
to the hospital.
continuously
as directed
on the unit label.
Returns accepted
with > 48 hours
to expiration
If < 48 notes:
hours, (day of expiration), contact Hospital Services, St. Paul. If unit
Memorial
Centers
NOT
accept
units for
can be •
used,
no charge, Blood
if it cannot
be used,will
hospital
will be
charged
without be
a return
> 3 monthsreturn
to outdate — may
returned reason and the initials of
the person shipping the units.
Memorial
consulted
for alternative
• Blood
The Centers
returnphysician
packing
slip generated
in Blood Hub
will document the tech, date and time of return
If hospital chooses not to use suggested alternative, hospital charged full cost
and will require checking an acceptance box
of imported component.
indicating that the units are acceptable for return
If no alternative,
Memorial Blood Centers assumes cost of imported
for reissue.
alternative.
Blood Hub generated return form below.
Rev. June 2015
Paper copy of Return/Transfer form (Form-HS-020)
An example of a Record of Return/Transfer form
(Form HS-020) is provided. Record of Return/
Transfer forms are provided free of charge. If you
need forms, call Hospital Services and they will be
sent with a routine order.
Component
Description
Storage
Comments
Temperature
Platelet Component
20 – 24o C
Continuous
agitation is
required
Buffy Coats
20 – 24o C
DO NOT AGITATE
Red Blood Cells
1 – 6o C
Frozen Component
< -18o C
NOTE: These storage guidelines are provided to assist
your facility in the proper storage temperature for
components. It is the responsibility of your facility to
follow all applicable storage regulations provided by
the AABB and FDA.
Transferring Units
Transferring Units to Another
Memorial Blood Centers Facility
Whenever possible, components should be returned to
Memorial Blood Centers for transfer to another facility.
However, if it becomes necessary to expedite the delivery,
you may be asked to transfer blood and/or blood
components directly to another facility. To do this:
• Arrange for transportation from your facility to
the hospital needing the blood and/or components.
Hospital Services may assist you in this effort, if
necessary call them directly.
• Complete the Record of Transfer in Blood Hub or
the facilities Computer system and indicate which
facility the units were transferred to. A paper
generated Record of Return/Transfer form may be
used if Blood Hub is not functioning (see example
on page 18.
• Notify Hospital Services by fax or phone that the
units were transferred.
• Instruct the receiving facility to complete the
Record of Return Transfer upon receipt of the
shipment and forward to Hospital Services.
Rev. June 2015
Transferring Units with a Patient to:
Hospitals Memorial Blood Centers Services
If the blood and/or blood components are transferred
with a patient to a hospital supplied by Memorial
Blood Centers:
• A Record of Return Transfer form must be
completed
• The blood and/or components must be received at
the proper storage temperature by the receiving
facility
NOTE: If the receiving facility will NOT accept the
units, it is your responsibility to charge the patient for
the units. Memorial Blood Centers will charge your
facility (original receiving facility) for these units.
Hospitals Memorial Blood Centers
Does Not Service
It is sometimes necessary to transport units with a
patient to a hospital Memorial Blood Centers does
not service. Blood and/or blood components may be
transferred to these facilities at your discretion.
Memorial Blood Centers hospitals that send blood
and/or blood components to hospitals that Memorial
Blood Centers does not serve will be charged for the
units. It is then up to you to charge the receiving
hospital appropriately.
These blood components may not be returned to
any hospital Memorial Blood Centers serves or to
Memorial Blood Centers itself. The sending hospital
is responsible for billing the receiving hospital for all
units involved. Please contact Hospital Services with
questions.
• Each Transfusion Service is responsible for
developing processes to comply with this
requirement.
Guidelines for Returning and
Packing of Red Blood Cells
Memorial Blood Center’s standard shipping box with
Styrofoam inserts should be used in combination with
gel packs, which have been frozen at approximately
-18oC.
Please refer to JobAid-HS-015.1 How to Pack Red
Blood Cells for Return which is distributed to hospital
customers. Call Hospital Services department
management if you do not have this JobAid at your
facility.
Guidelines for Packing Platelets
1. Memorial Blood Center’s standard shipping box with
the Styrofoam inserts may be used only for routine in
town shipments, which are expected to be less than 2
hours, when outside temperatures are between 40oF
and 85oF.
2. Memorial Blood Center’s platelet shipping container
with molded foam sides can be used for any
platelet shipment and should be used for platelet
shipments expected to take >2 hours or when outside
temperature are >85oF or <40oF.
Inventory Reconciliation
FDA and AABB Standards require that it be possible
to trace any unit of blood or component from
source (the donor or the collecting facility) to final
disposition (transfused, shipped, and/or discarded).
Memorial Blood Centers uses several different
processes to meet this requirement:
• Memorial Blood Centers will involve Transfusion
Services in a periodic reconciliation of physical
inventories and inventory records.
• Transfusion Services staff is responsible for
assisting Memorial Blood Centers staff in the
reconciliation of any discrepancies.
• Transfusion Services may be asked to provide
final disposition information to Memorial Blood
Centers to complete the blood center records.
Rev. June 2015
Memorial Blood Centers Standard Shipping Box
1. Place 1 additional Styrofoam sheet on the bottom of the shipping box
2. Ensure plastic liner is inside the shipping box
3. Place 1 three pound room temp gel pack on the bottom of the box
4. Place component(s) on top of the gel pack
5. Place 1 additional three pound gel pack on the top of the component(s)
6. Wrap plastic liner securely around the components(s)
7. Place 2 Styrofoam sheets on the top of the gel packs
Memorial Blood Centers Platelet Shipping Box
1. Ensure plastic liner is inside the shipping box
2. Place 1 three pound room temp gel pack on the bottom of the box
3. Place components(s) on top of the gel pack
4. Place 1 additional three pound gel pack on the top of the component(s)
5. Wrap plastic liner securely around the component(s)
6. Place foam insert on the top of the units and gently push to secure
Rev. June 2015
Product Codes
Memorial Blood Centers Transfusable Blood
Product Codes Manufactured at MBC
Whole Blood
MBC
Code
ISBT Product
Code
Product Description
THER
B0009
Whole Blood Therapeutic Draw (component is created and discarded)
E0052
E0052
WHOLE BLOOD|CPD/XX/refg|LowVol:anticoag not adj
E0130
E0130
WHOLE BLOOD|CP2D/XX/refg|LowVol:anticoag not adj
E4150
E4150
WHOLE BLOOD|CPD/XX/refg|LowVol:anticoag adj
E4152
E4152
WHOLE BLOOD|CPDA-1/XX/refg|LowVol:anticoag adj
E4153
E4153
WHOLE BLOOD|CP2D/XX/refg|LowVol:anticoag adj
E5013
E5013
WHOLE BLOOD|CPD/XX/refg|Irradiated|LowVol:anticoag not adj
E5014
E5014
WHOLE BLOOD|CPD/XX/refg|Irradiated|LowVol:anticoag adj
E5015
E5015
WHOLE BLOOD|CPDA-1/XX/refg|Irradiated|LowVol:anticoag not adj
E5016
E5016
WHOLE BLOOD|CPDA-1/XX/refg|Irradiated|LowVol:anticoag adj
E5120
E5120
WHOLE BLOOD|CPDA-1/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag not adj
E5121
E5121
WHOLE BLOOD|CPDA-1/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag adj
E5559
E5559
WHOLE BLOOD|CP2D/XX/refg|Irradiated|LowVol:anticoag adj
E5560
E5560
WHOLE BLOOD|CPD/XX/refg|ResLeu:<5log6|LowVol:anticoag adj
E5561
E5561
WHOLE BLOOD|CP2D/XX/refg|ResLeu:<5log6|LowVol:anticoag adj
E5562
E5562
WHOLE BLOOD|CPD/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag adj
E5563
E5563
WHOLE BLOOD|CP2D/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag adj
E5564
E5564
WHOLE BLOOD|CP2D/XX/refg|Irradiated|LowVol:anticoag not adj
E5565
E5565
WHOLE BLOOD|CPD/XX/refg|ResLeu:<5log6|LowVol:anticoag not adj
E5566
E5566
WHOLE BLOOD|CPDA-1/XX/refg|ResLeu:<5log6|LowVol:anticoag not adj
E5567
E5567
WHOLE BLOOD|CP2D/XX/refg|ResLeu:<5log6|LowVol:anticoag notadj
E5568
E5568
WHOLE BLOOD|CPD/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag not adj
E5569
E5569
WHOLE BLOOD|CP2D/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag not adj
WB2
E0112
WHOLE BLOOD|CP2D/500mL/refg
WB2I
E0120
WHOLE BLOOD|CP2D/500mL/refg|Irradiated
WBI*
E0031
WHOLE BLOOD|CPD/500mL/refg|Irradiated
WB*
E0023
WHOLE BLOOD|CPD/500mL/refg
E5612
E5612
WHOLE BLOOD|CPDA-1/XX/refg|ResLeu:<5log6|LowVol:anticoag adj
Frozen RBC
MBC
Code
ISBT Product
Code
Product Description
FZ
E5079
Frozen RED BLOOD CELLS|None/XX/<-65C|Open
FZD
E4520
Deglycerolized RED BLOOD CELLS|None/XX/refg|Open
FZDI
E4522
Deglycerolized RED BLOOD CELLS|None/XX/refg|Open|Irradiated
FZI
E5081
Frozen RED BLOOD CELLS|None/XX/<-65C|Open|Irradiated
RFZ*
E5171
Frozen Rejuvenated RED BLOOD CELLS|None/XX/<-65C|Open
RFZI*
E5176
Frozen Rejuvenated RED BLOOD CELLS|None/XX/<-65C|Open|Irradiated
RFZD*
E5174
Deglycerolized Rejuvenated RED BLOOD CELLS|None/XX/refg|Open
RFZDI*
E5180
Deglycerolized Rejuvenated RED BLOOD CELLS|None/XX/Refg|Open|Irradiated
Rev. June 2015
Product Codes • Page 22
Non-Leukoreduced RBC
MBC
Code
ISBT Product
Code
Product Description
PC1
E0316
RED BLOOD CELLS|CPD>AS1/500mL/refg
PC1I
E0331
RED BLOOD CELLS|CPD>AS1/500mL/refg|Irradiated
PC2*
E0262
RED BLOOD CELLS|CP2D/500mL/refg
PC2I*
E0273
RED BLOOD CELLS|CP2D/500mL/refg|Irradiated
PC3*
E0366
RED BLOOD CELLS|CP2D>AS3/500mL/refg
E0375
Red Blood Cells, CP2D, AS-3, Leukoreduced, Syringe Aliquot (suffix indicated as A0, B0, Ba, Bb, Bc, Bd, etc.)
E0372
Red Blood Cells, CP2D, AS-3, Leukoreduced, Syringe Aliquot, Irradiated (suffix indicated as A0, B0, Ba, Bb, Bc, Bd, etc.)
PC3I*
E0378
RED BLOOD CELLS|CP2D>AS3/500mL/refg|Irradiated
PCA
E0212
RED BLOOD CELLS|CPDA-1/500mL/refg
PCAI
E0223
RED BLOOD CELLS|CPDA-1/500mL/refg|Irradiated
PCC*
E0167
RED BLOOD CELLS|CPD/500mL/refg
PCCI*
E0178
RED BLOOD CELLS|CPD/500mL/refg|Irradiated
PCW
E5160
Washed RED BLOOD CELLS|None/XX/refg|Open
PCWI
E5168
Washed RED BLOOD CELLS|None/XX/refg|Open|Irradiated
PED1
E0212
PED1I
E0223
PED2
E0212
PED2I
E0223
PED3
E0212
E0605
Apheresis Red Blood Cells, CP2D, AS-3, Non-Leukoreduced
E0693***
E0693
Apheresis Red Blood Cells, CP2D, AS-3, Non-Leukoreduced, Bag 1
E0694***
E0694
Apheresis Red Blood Cells, CP2D, AS-3, Non-Leukoreduced, Bag 2
PED3I
E0223
PED4
E0212
PED4I
E0223
PED5
E0212
PED5I
E0223
B0018
B0018
RBC/CPD/500ml/refg/open/plasma reduced
B0019
B0019
RBC/CPD/500ml/refg/open/plasma reduced/irradiated
E0244***
E0244
RED BLOOD CELLS|CPDA-1/XX/refg|LowVol:anticoag not adj
E0283***
E0283
RED BLOOD CELLS|CP2D/XX/refg|LowVol:anticoag not adj
E0463***
E0463
RED BLOOD CELLS|CPD>AS1/XX/refg|LowVol:anticoag not adj
E0465***
E0465
RED BLOOD CELLS|CP2D>AS3/XX/refg|LowVol:anticoag not adj
E4154***
E4154
RED BLOOD CELLS|CPDA-1/XX/refg|LowVol:anticoag adj
E5247***
E5247
RED BLOOD CELLS|CPDA-1/XX/refg|Irradiated|LowVol:anticoag adj
E4155***
E4155
RED BLOOD CELLS|CP2D/XX/refg|LowVol:anticoag adj
E4156***
E4156
RED BLOOD CELLS|CPD>AS1/XX/refg|LowVol:anticoag adj
E4157***
E4157
RED BLOOD CELLS|CP2D>AS3/XX/refg|LowVol:anticoag adj
E5249***
E5249
RED BLOOD CELLS|CP2D>AS3/XX/refg|Irradiated|LowVol:anticoag adj
E5017***
E5017
RED BLOOD CELLS|CPD/XX/refg|LowVol:anticoag not adj
E5018***
E5018
RED BLOOD CELLS|CPD/XX/refg|LowVol:anticoag adj
E5067***
E5067
RED BLOOD CELLS|CPD/XX/refg|Irradiated|LowVol:anticoag not adj
E5070***
E5070
RED BLOOD CELLS|CPD>AS1/XX/refg|Irradiated|LowVol:anticoag not adj
E5071***
E5071
RED BLOOD CELLS|CPD>AS1/XX/refg|Irradiated|LowVol:anticoag adj
E5161***
E5161
RED BLOOD CELLS|CPD/XX/refg|Irradiated|LowVol:anticoag adj
E5246***
E5246
RED BLOOD CELLS|CPDA-1/XX/refg|Irradiated|LowVol:anticoag not adj
E5247***
E5247
RED BLOOD CELLS|CPDA-1/XX/refg|Irradiated|LowVol:anticoag adj
E5248***
E5248
RED BLOOD CELLS|CP2D>AS3/XX/refg|Irradiated|LowVol:anticoag not adj
Rev. June 2015
Non-Leukoreduced RBC
MBC
Code
ISBT Product
Code
Product Description
E5249***
E5249
RED BLOOD CELLS|CP2D>AS3/XX/refg|Irradiated|LowVol:anticoag adj
E5553***
E5553
RED BLOOD CELLS|CP2D/XX/refg|Irradiated|LowVol:anticoag adj
E5557***
E5557
RED BLOOD CELLS|CP2D/XX/refg|Irradiated|LowVol:anticoag not adj
E5671
E5671
RBC/CPDA-1/500ml/refg/open/plasma reduced
E5672
E5672
RBC/CPDA-1/500ml/refg/open/plasma reduced/irradiated
E5673
E5673
RBC/CPD/500ml/refg/open/plasma reduced/plasma added
E5674
E5674
RBC/CPD/500ml/refg/open/plasma reduced/irradiated/plasma added
E5675
E5675
RBC/CPDA-1/500ml/refg/open/plasma reduced/plasma added
E5676
E5676
RBC/CPDA-1/500ml/refg/open/plasma reduced/irradiated/plasma added
AR1*
E4534
Apheresis RED BLOOD CELLS|ACD-A>AS1/XX/refg|1st container
AR1I
E4529
Apheresis RED BLOOD CELLS|ACD-A>AS1/XX/refg|Irradiated|1st container
AR1W
E4566
Washed Apheresis RED BLOOD CELLS|None/XX/refg|Open|1st container
AR1WI
E4562
Washed Apheresis RED BLOOD CELLS|None/XX/refg|Open|Irradiated|1st container
AR2*
E4535
Apheresis RED BLOOD CELLS|ACD-A>AS1/XX/refg|2nd container
AR2I
E4530
Apheresis RED BLOOD CELLS|ACD-A>AS1/XX/refg|Irradiated|2nd container
AR2W
E4567
Washed Apheresis RED BLOOD CELLS|None/XX/refg|Open|2nd container
AR2WI
E4563
Washed Apheresis RED BLOOD CELLS|None/XX/refg|Open|Irradiated|2nd container
E0150
E0150
RED BLOOD CELLS|CPD/450mL/refg
E0161
E0161
RED BLOOD CELLS|CPD/450mL/refg|Irradiated
E0195
E0195
E0206
E0206
E0245
E0245
RED BLOOD CELLS|CP2D/450mL/refg
E0256
E0256
RED BLOOD CELLS|CP2D/450mL/refg|Irradiated
E0291
E0291
E0306
E0306
E0341
E0341
RED BLOOD CELLS|CP2D>AS3/450mL/refg
E0356
E0356
RED BLOOD CELLS|CP2D>AS3/450mL/refg|Irradiated
E0385
E0385
E0397
E0397
E0467***
E0467
RED BLOOD CELLS|CPD>AS5/XX/refg|LowVol:anticoag not adj
E0676***
E0676
Apheresis RED BLOOD CELLS|CP2D>AS3/XX/refg|Irradiated|1st container
E0677***
E0677
Apheresis RED BLOOD CELLS|CP2D>AS3/XX/refg|Irradiated|2nd container
E0693
E0693
Apheresis RED BLOOD CELLS|CP2D>AS3/XX/refg|1st container
E0694
E0694
Apheresis RED BLOOD CELLS|CP2D>AS3/XX/refg|2nd container
E5250***
E5250
RED BLOOD CELLS|CPD>AS5/XX/refg|Irradiated|LowVol:anticoag not adj
E5251
E5251
RED BLOOD CELLS|CPD>AS5/XX/refg|Irradiated|LowVol:anticoag adj
E4158
E4158
RED BLOOD CELLS|CPD>AS5/XX/refg|LowVol:anticoag adj
E4541***
E4541
Apheresis RED BLOOD CELLS|ACD-A>AS3/XX/refg|Irradiated|1st container
E4542***
E4542
Apheresis RED BLOOD CELLS|ACD-A>AS3/XX/refg|Irradiated|2nd container
E4546***
E4546
Apheresis RED BLOOD CELLS|ACD-A>AS3/XX/refg|1st container
E4547***
E4547
Apheresis RED BLOOD CELLS|ACD-A>AS3/XX/refg|2nd container
PC5*
E0404
PC5I*
E0419
Leukoreduced RBC
MBC
Code
ISBT Product
Code
Product Description
BC
E3732
LEUKOCYTES|CPD/500mL/rt
Rev. June 2015
Leukoreduced RBC
MBC
Code
ISBT Product
Code
Product Description
BCA1
E3742
LEUKOCYTES|CPDA-1/500mL/rt
BCA1I
E5552
LEUKOCYTES|CPDA-1/500mL/rt|Irradiated
BCI
E5551
LEUKOCYTES|CPD/500mL/rt|Irradiated
LAR1
E4532
Apheresis RED BLOOD CELLS|ACD-A>AS1/XX/refg|ResLeu:<5log6|1st container
LAR1A
E4532
LAR1AI
E4527
Apheresis RED BLOOD CELLS|ACD-A>AS1/XX/refg|Irradiated|ResLeu:<5log6|1st container
LAR1B
E4532
LAR1BI
E4527
LAR1I
E4527
LAR1W
E4564
Washed Apheresis RED BLOOD CELLS|None/XX/refg|Open|ResLeu:<5log6|1st container
LAR1WI
E4560
Washed Apheresis RED BLOOD CELLS|None/XX/refg|Open|Irradiated|ResLeu:<5log6|1st container
LAR2
E4533
Apheresis RED BLOOD CELLS|ACD-A>AS1/XX/refg|ResLeu:<5log6|2nd container
LAR2A
E4533
LAR2AI
E4528
Apheresis RED BLOOD CELLS|ACD-A>AS1/XX/refg|Irradiated|ResLeu:<5log6|2nd container
LAR2B
E4533
LAR2BI
E4528
LAR2I
E4528
LAR2W
E4565
Washed Apheresis RED BLOOD CELLS|None/XX/refg|Open|ResLeu:<5log6|2nd container
LAR2WI
E4561
Washed Apheresis RED BLOOD CELLS|None/XX/refg|Open|Irradiated|ResLeu:<5log6|2nd container
E4543
E4543
Apheresis RED BLOOD CELLS|ACD-A>AS3/XX/refg/Leu:<5log6
E4538
E4538
Apheresis RED BLOOD CELLS|ACD-A>AS3/XX/refg|Irradiated|ResLeu:<5log6
E4544
E4544
Apheresis RED BLOOD CELLS|ACD-A>AS3/XX/refg/Leu:<5log6/|1st container
E4539
E4539
E4545
E4545
Apheresis RED BLOOD CELLS|ACD-A>AS3/XX/refg/Leu:<5log6/|2nd container
E4540
E4540
E4144
E4144
Washed Apheresis RBC/none/xx/refg/open/ResLeu:<5log6
E4145
E4145
Washed Apheresis RBC/none/xx/refg/open/Irradiated/ResLeu:<5log6
LPC1
E0336
RED BLOOD CELLS|CPD>AS1/500mL/refg|ResLeu:<5log6
LPC1I
E0332
RED BLOOD CELLS|CPD>AS1/500mL/refg|Irradiated|ResLeu:<5log6
LPC2*
E0276
RED BLOOD CELLS|CP2D/500mL/refg|ResLeu:<5log6
LPC2I*
E0274
RED BLOOD CELLS|CP2D/500mL/refg|Irradiated|ResLeu:<5log6
LPC3*
E0382
RED BLOOD CELLS|CP2D>AS3/500mL/refg|ResLeu:<5log6
LPC3I*
E0379
RED BLOOD CELLS|CP2D>AS3/500mL/refg|Irradiated|ResLeu:<5log6
E0678
Apheresis Red Blood Cells, CP2D, AS-3, Leukoreduced (Single collection)
E0661
Apheresis Red Blood Cells, CP2D, AS-3, Leukoreduced, Irradiated (Single collection)
E0685***
E0685
Apheresis Red Blood Cells, CP2D, AS-3, Leukoreduced, Bag 1
E0668**
E0668
Apheresis Red Blood Cells, CP2D, AS-3, Leukoreduced, Irradiated (Single collection)
E0686***
E0686
Apheresis Red Blood Cells, CP2D, AS-3, Leukoreduced, Bag 2
E0669***
E0669
Apheresis Red Blood Cells, CP2D, AS-3, Leukoreduced, Bag 2, Irradiated
LPCA
E0226
RED BLOOD CELLS|CPDA-1/500mL/refg|ResLeu:<5log6
LPCAI
E0224
RED BLOOD CELLS|CPDA-1/500mL/refg|Irradiated|ResLeu:<5log6
LPCC*
E0181
RED BLOOD CELLS|CPD/500mL/refg|ResLeu:<5log6
LPCCI*
E0179
RED BLOOD CELLS|CPD/500mL/refg|Irradiated|ResLeu:<5log6
LPCW
E5169
Washed RED BLOOD CELLS|None/XX/refg|Open|ResLeu:<5log6
LPCWI
E5170
Washed RED BLOOD CELLS|None/XX/refg|Open|Irradiated|ResLeu:<5log6
LPED1
E0226
LPED1I
E0224
LPED2
E0226
LPED2I
E0224
Rev. June 2015
Leukoreduced RBC
MBC
Code
ISBT Product
Code
Product Description
LPED3
E0226
LPED3I
E0224
LPED4
E0226
LPED4I
E0224
LPED5
E0226
LPED5I
E0224
PUBS
B0017
Washed RED BLOOD CELLS|None/500mL/refg|Open|Irradiated|ResLeu:<5log6|supernatant removed
E5362
E5362
RBC/CPD-500ml/refg/open/plasma reduced/res leu <5log6/irradiated/plasma added
E5363
E5363
RBC/CPD/500ml/refg/open/plasma reduced/res leu <5log6/plasma added
E5365
E5365
RBC/CPD/500ml/refg/open/plasma reduced/res leu <5log6
E5536***
E5536
RBC/CPDA-1/500ml/refg/open/plasma reduced/res leu <5log6/irradiated
E5627
E5627
RBC/CPDA-1/500ml/refg/open/plasma reduced/res leu <5log6
E5670
E5670
RBC/CPD-500ml/refg/open/plasma reduced/res leu <5log6/irradiated
E5677
E5677
RBC/CPDA-1/500ml/refg/open/plasma reduced/res leu <5log6/plasma added
E5678
E5678
RBC/CPDA-1/500ml/refg/open/plasma reduced/res leu <5log6/irradiated/plasma added
E5526
Reconstituted Whole Blood, from AS-3, 500 mL CP2D Whole Blood, Leukocytes Reduced
E5545
Red Blood Cells, AS-3, Supernatant Reduced
E5527
Reconstituted Whole Blood, from AS-3, 500 mL CP2D Whole Blood, Leukocytes Reduced, Irradiated
E5539
Red Blood Cells, AS-3, Supernatant Reduced, Irradiated
E0162
E0162
RED BLOOD CELLS|CPD/450mL/refg|Irradiated|ResLeu:<5log6
E0164
E0164
RED BLOOD CELLS|CPD/450mL/refg|ResLeu:<5log6
E0207
E0207
E0209
E0209
E0257
E0257
RED BLOOD CELLS|CP2D/450mL/refg|Irradiated|ResLeu:<5log6
E0259
E0259
RED BLOOD CELLS|CP2D/450mL/refg|ResLeu:<5log6
E0307
E0307
E0311
E0311
E0357
E0357
RED BLOOD CELLS|CP2D>AS3/450mL/refg|Irradiated|ResLeu:<5log6
E0361
E0361
RED BLOOD CELLS|CP2D>AS3/450mL/refg|ResLeu:<5log6
E0398
E0398
E0401
E0401
E0669
E0669
Apheresis RED BLOOD CELLS|CP2D>AS3/XX/refg|Irradiated|ResLeu:<5log6|2nd container
E0685
E0685
Apheresis RED BLOOD CELLS|CP2D>AS3/XX/refg|ResLeu:<5log6|1st container
E0686
E0686
Apheresis RED BLOOD CELLS|CP2D>AS3/XX/refg|ResLeu:<5log6|2nd container
E5122***
E5122
RED BLOOD CELLS|CPD>AS1/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag not adj
E5123
E5123
RED BLOOD CELLS|CPD>AS1/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag adj
E5124***
E5124
RED BLOOD CELLS|CP2D>AS3/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag not adj
E5125
E5125
RED BLOOD CELLS|CP2D>AS3/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag adj
E5126***
E5126
RED BLOOD CELLS|CPD>AS5/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag not adj
E5127
E5127
RED BLOOD CELLS|CPD>AS5/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag adj
E5155***
E5155
RED BLOOD CELLS|CPDA-1/XX/refg|ResLeu:<5log6|LowVol:anticoag not adj
E5156
E5156
RED BLOOD CELLS|CPDA-1/XX/refg|ResLeu:<5log6|LowVol:anticoag adj
E5157***
E5157
RED BLOOD CELLS|CPD>AS1/XX/refg|ResLeu:<5log6|LowVol:anticoag not adj
E5158
E5158
RED BLOOD CELLS|CPD>AS1/XX/refg|ResLeu:<5log6|LowVol:anticoag adj
E5240***
E5240
RED BLOOD CELLS|CPD/XX/refg|ResLeu:<5log6|LowVol:anticoag not adj
E5241
E5241
RED BLOOD CELLS|CPD/XX/refg|ResLeu:<5log6|LowVol:anticoag adj
E5242***
E5242
RED BLOOD CELLS|CP2D>AS3/XX/refg|ResLeu:<5log6|LowVol:anticoag not adj
E5243
E5243
RED BLOOD CELLS|CP2D>AS3/XX/refg|ResLeu:<5log6|LowVol:anticoag adj
E5244***
E5244
RED BLOOD CELLS|CPD>AS5/XX/refg|ResLeu:<5log6|LowVol:anticoag not adj
Rev. June 2015
Leukoreduced RBC
MBC
Code
ISBT Product
Code
Product Description
E5245
E5245
RED BLOOD CELLS|CPD>AS5/XX/refg|ResLeu:<5log6|LowVol:anticoag adj
E5252***
E5252
RED BLOOD CELLS|CPD/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag not adj
E5253
E5253
RED BLOOD CELLS|CPD/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag adj
E5376***
E5376
RED BLOOD CELLS|CPDA-1/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag not adj
E5554
E5554
RED BLOOD CELLS|CP2D/XX/refg|ResLeu:<5log6|LowVol:anticoag adj
E5555
E5555
RED BLOOD CELLS|CPDA-1/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag adj
E5556
E5556
RED BLOOD CELLS|CP2D/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag adj
E5558***
E5558
RED BLOOD CELLS|CP2D/XX/refg|Irradiated|ResLeu:<5log6|LowVol:anticoag not adj
E5611***
E5611
RED BLOOD CELLS|CP2D/XX/refg|ResLeu:<5log6|LowVol:anticoag not adj
LPC5*
E0424
LPC5I*
E0420
SUR
B0023
Single Unit Recovery|Aph RBCs|ACD-A>AS1|XX
Apheresis Platelets
MBC
Code
ISBT Product
Code
Product Description
LPH
E3077
Apheresis PLATELETS|ACD-A/XX/20-24C|ResLeu:<5log6
E3078
Apheresis Platelets, Leukoreduced, Plasma Reduced (Single collection)
E3047
Apheresis Platelets, Leukoreduced, Plasma Reduced, Irradiated (Single collection)
E3080
Apheresis Platelets, Leukoreduced, Plasma Reduced, Bag 1
E3049
Apheresis Platelets, Leukoreduced, Plasma Reduced, Bag 1, Irradiated
E0381
Apheresis Platelets, Leukoreduced, Plasma Reduced, Bag 2
E3050
Apheresis Platelets, Leukoreduced, Plasma Reduced, Bag 2, Irradiated
LPH1
E3087
Apheresis PLATELETS|ACD-A/XX/20-24C|ResLeu:<5log6|1st container
LPH1A
E3087
LPH1AI
E3056
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|ResLeu:<5log6|1st container
LPH1B
E3087
LPH1BI
E3056
LPH1I
E3056
LPH1V
E3017
Apheresis PLATELETS|ACD-A/XX/20-24C|Open|ResLeu:<5log6|Plasma reduced|1st container
LPH1VI
E2986
Apheresis PLATELETS|ACD-A/XX/20-24C|Open|Irradiated|ResLeu:<5log6|Plasma reduced|1st container
LPH1W
E3558
Washed Apheresis PLATELETS|None/XX/20-24C|Open|ResLeu:<5log6|1st container
LPH1WI
E3543
Washed Apheresis PLATELETS|None/XX/20-24C|Open|Irradiated|ResLeu:<5log6|1st container
LPH2
E3088
Apheresis PLATELETS|ACD-A/XX/20-24C|ResLeu:<5log6|2nd container
LPH2A
E3088
LPH2AI
E3057
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|ResLeu:<5log6|2nd container
LPH2B
E3088
LPH2BI
E3057
LPH2I
E3057
LPH2V
E3018
Apheresis PLATELETS|ACD-A/XX/20-24C|Open|ResLeu:<5log6|Plasma reduced|2nd container
LPH2VI
E2987
Apheresis PLATELETS|ACD-A/XX/20-24C|Open|Irradiated|ResLeu:<5log6|Plasma reduced|2nd container
LPH2W
E3559
Washed Apheresis PLATELETS|None/XX/20-24C|Open|ResLeu:<5log6|2nd container
LPH2WI
E3544
Washed Apheresis PLATELETS|None/XX/20-24C|Open|Irradiated|ResLeu:<5log6|2nd container
LPH3
E3089
Apheresis PLATELETS|ACD-A/XX/20-24C|ResLeu:<5log6|3rd container
LPH3A
E3089
LPH3AI
E3058
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|ResLeu:<5log6|3rd container
LPH3B
E3089
LPH3BI
E3058
Rev. June 2015
Apheresis Platelets
MBC
Code
ISBT Product
Code
Product Description
LPH3I
E3058
LPH3V
E3019
Apheresis PLATELETS|ACD-A/XX/20-24C|Open|ResLeu:<5log6|Plasma reduced|3rd container
LPH3VI
E2988
Apheresis PLATELETS|ACD-A/XX/20-24C|Open|Irradiated|ResLeu:<5log6|Plasma reduced|3rd container
LPH3W
E3560
Washed Apheresis PLATELETS|None/XX/20-24C|Open|ResLeu:<5log6|3rd container
LPH3WI
E3545
Washed Apheresis PLATELETS|None/XX/20-24C|Open|Irradiated|ResLeu:<5log6|3rd container
LPHA
E3077
LPHAI
E3046
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|ResLeu:<5log6
LPHB
E3077
LPHBI
E3046
LPHC
E4643
Apheresis PLATELETS|ACD-A/XX/20-24C|ResLeu:<5log6|<3log11 plts
LPHC1
E4644
Apheresis PLATELETS|ACD-A/XX/20-24C|ResLeu:<5log6|1st container|<3log11 plts
LPHC1I
E4648
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|ResLeu:<5log6|1st container|<3log11 plts
LPHC2
E4645
Apheresis PLATELETS|ACD-A/XX/20-24C|ResLeu:<5log6|2nd container|<3log11 plts
LPHC2I
E4649
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|ResLeu:<5log6|2nd container|<3log11 plts
LPHC3
E4646
Apheresis PLATELETS|ACD-A/XX/20-24C|ResLeu:<5log6|3rd container|<3log11 plts
LPHC3I
E4650
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|ResLeu:<5log6|3rd container|<3log11 plts
LPHCI
E4647
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|ResLeu:<5log6|<3log11 plts
LPHI
E3046
LPHV
E3015
Apheresis PLATELETS|ACD-A/XX/20-24C|Open|ResLeu:<5log6|Plasma reduced
LPHVI
E2984
Apheresis PLATELETS|ACD-A/XX/20-24C|Open|Irradiated|ResLeu:<5log6|Plasma reduced
LPHW
E3556
Washed Apheresis PLATELETS|None/XX/20-24C|Open|ResLeu:<5log6
LPHWI
E3541
Washed Apheresis PLATELETS|None/XX/20-24C|Open|Irradiated|ResLeu:<5log6
PH1 *
E3102
Apheresis PLATELETS|ACD-A/XX/20-24C|1st container
PH1I*
E3071
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|1st container
PH2*
E3103
Apheresis PLATELETS|ACD-A/XX/20-24C|2nd container
PH2I*
E3072
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|2nd container
PHC*
E4635
Apheresis PLATELETS|ACD-A/XX/20-24C|<3log11 plts
PHC1*
E4636
Apheresis PLATELETS|ACD-A/XX/20-24C|1st container|<3log11 plts
PHC1I*
E4640
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|1st container|<3log11 plts
PHC2*
E4637
Apheresis PLATELETS|ACD-A/XX/20-24C|2nd container|<3log11 plts
PHC2I*
E4641
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|2nd container|<3log11 plts
PHCI*
E4639
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated|<3log11 plts
PHI*
E3045
Apheresis PLATELETS|ACD-A/XX/20-24C|Irradiated
PV
E5346
PLATELETS|CPD/500mL/20-24C|Open|Plasma reduced
PVI
E5347
PLATELETS|CPD/500mL/20-24C|Open|Irradiated|Plasma reduced
PW
E2889
Washed PLATELETS|None/XX/20-24C|Open
PWI
E2890
Washed PLATELETS|None/XX/20-24C|Open|Irradiated
E2807
E2807
PLATELETS|CPD/450mL/20-24C
E2809
E2809
PLATELETS|CPD/450mL/20-24C|Irradiated
E2833
E2833
PLATELETS|CPDA-1/450mL/20-24C
E2835
E2835
PLATELETS|CPDA-1/450mL/20-24C|Irradiated
E2851
E2851
PLATELETS|CP2D/450mL/20-24C
E2853
E2853
PLATELETS|CP2D/450mL/20-24C|Irradiated
E2854
E2854
PLATELETS|CP2D/450mL/20-24C|Irradiated|ResLeu:<8.3log5
E2857
E2857
Platelets|CP2D/450mL/20-24C|ResLeu:<8.3log5
Rev. June 2015
Platelet from Whole Blood
MBC
Code
ISBT Product
Code
Product Description
PL
E2824
PLATELETS|CPD/500ml/20-24C
PL2D*
E2860
PLATELETS|CP2D/500mL/20-24C
PL2DI*
E2862
PLATELETS|CP2D/500mL/20-24C|Irradiated
PLA1*
E2842
PLATELETS|CPDA-1/500mL/20-24C
PLA1I*
E2844
PLATELETS|CPDA-1/500mL/20-24C|Irradiated
PLI
E2826
PLATELETS|CPD/500mL/20-24C|Irradiated
LPL
E2866
Platelets|CP2D/500mL/20-24C|ResLeu:<8.3log5
LPLI
E2863
PLATELETS|CP2D/500mL/20-24C|Irradiated|ResLeu:<8.3log5
LPLV
E5613
PLATELETS|CP2D/500mL/20-24C|Open|ResLeu:<8.3log5|Plasma reduced
LPLVI
E5614
PLATELETS|CP2D/500mL/20-24C|Open|Irradiated|ResLeu:<8.3log5|Plasma reduced
LPLW
E2894
Washed PLATELETS|None/XX/20-24C|Open|ResLeu:<8.3log5
LPLWI
E2891
Washed PLATELETS|None/XX/20-24C|Open|Irradiated|ResLeu:<8.3log5
Pooled Platelets
MBC
Code
ISBT Product
Code
Product Description
LPP
E5710
POOLED PLATELETS|CP2D/XX/20-24C|ResLeu:<5log6|Bacterial monitoring
LPPI
E5709
POOLED PLATELETS|CP2D/XX/20-24C|Irradiated|ResLeu:<5log6|Bacterial monitoring
LPPV
E5650
POOLED PLATELETS|CP2D/XX/20-24C|Open|ResLeu:<5log6|Bacterial monitoring/Plasma reduced
LPPVI
E5649
POOLED PLATELETS|CP2D/XX/20-24C|Open|Irradiated|ResLeu:<5log6|Bacterial monitoring/Plasma reduced
LPPVS
B0021
POOLED PLATELETS|CP2D/XX/20-24C|Open|ResLeu:<5log6|Bacterial monitoring/Plasma reduced/Saline added
LPPVSI
B0022
POOLED PLATELETS|CP2D/XX/20-24C|Open|Irradiated|ResLeu:<5log6|Bacterial monitoring/Plasma reduced/Saline added
LPPW
E2921
Washed 'POOLED PLATELETS|None/XX/20-24C|Open|ResLeu:<5log6|Bacterial monitoring
LPPWI
E2920
Washed POOLED PLATELETS|None/XX/20-24C|Open|Irradiated|ResLeu:<5log6|Bacterial monitoring
E2983
Aph PLTS|ACD-A/Syringe Aliquot|Irrad|ResLeu:<5log6 (suffix indicated as A0, Ba, Bb, Bc, Bd, etc.)
E2993
Aph PLTS|ACD-A/Syringe Aliquot|Irrad|ResLeu:<5log6|1st cnt (suffix indicated as A0, Ba, Bb, Bc, Bd, etc.)
E2994
Aph PLTS|ACD-A/Syringe Aliquot|Irrad|ResLeu:<5log6|2nd cnt (suffix indicated as A0, Ba, Bb, Bc, Bd, etc.)
PP*
E5151
POOLED PLATELETS|CPD/XX/20-24C|Open
PPI*
E5226
POOLED PLATELETS|CPD/XX/20-24C|Open|Irradiated
PPV*
E5348
POOLED PLATELETS|CPD/XX/20-24C|Open|Plasma reduced
PPVI*
E5349
POOLED PLATELETS|CPD/XX/20-24C|Open|Irradiated|Plasma reduced
PPVS*
B0002
POOLED PLATELETS|NS/XX/20-24C|Open|Plasma reduced|Saline added
PPVSI*
B0003
POOLED PLATELETS|NS/XX/20-24C|Open|Irradiated|Plasma reduced|Saline added
PPW*
E2918
Washed POOLED PLATELETS|None/XX/20-24C|Open
PPWI*
E2919
Washed POOLED PLATELETS|None/XX/20-24C|Open|Irradiated
MBC
Code
ISBT Product
Code
Product Description
AFP
B0010
AUTOLOGOUS PLASMA (component is created and discarded)
CP*
E3588
POOLED CRYOPRECIPITATE|None/XX/<=-18C|Open
CPP
E2553
PLASMA|CPD/XX/<=-18C|Cryo reduced
CPP2D*
E2617
PLASMA|CP2D/XX/<=-18C|Cryo reduced
CPPA1
E2585
PLASMA|CPDA-1/XX/<=-18C|Cryo reduced
CR
E5165
CRYOPRECIPITATE|None/NS/<=-18C
E3587
Cryoprecipitated AHF, Pooled at Production
E3581
Thawed CRYOPRECIPITATE|None/NS/XX
Plasma
Rev. June 2015
Plasma
MBC
Code
ISBT Product
Code
Product Description
E3591
Cryprecipitated AHF, Pooled
E5304
Thawed Pooled plasma|CPD/XX/refg/Open|Cryp reduced
E5305
Thawed Pooled plasma|CP2D/XX/refg|Open|Cryo reduced
E2736
Thawed PLASMA|CP2D/XX/refg|Cryo reduced
E2720
Thawed PLASMA|CP2D/XX/refg
E2701
Thawed PLASMA |CPD/XX/refg|Frozen <=24h
E0773
Thawed PLASMA|CPD/XX/refg|Cryo reduced
FF
E0701
FRESH FROZEN PLASMA|CPD/XX/<=-18C
FF1
E0707
FRESH FROZEN PLASMA|CPDA-1/XX/<=-18C
FF2
E0707
FF2DI*
E0716
FRESH FROZEN PLASMA|CP2D/XX/<=-18C|Irradiated
FF3
E0707
FF4*
E0707
FFA1
E0707
FFA1I*
E0710
FRESH FROZEN PLASMA|CPDA-1/XX/<=-18C|Irradiated
FFI*
E0704
FRESH FROZEN PLASMA|CPD/XX/<=-18C|Irradiated
FFPP
E0869
Apheresis FRESH FROZEN PLASMA|ACD-A/XX/<=-18C
FFPP1
E0869
Apheresis Fresh FROZEN PLASMA|ACD-A/XX/<=-18C|Open|1st container
FFPP2
E0869
Apheresis Fresh FROZEN PLASMA|ACD-A/XX/<=-18C|Open|2nd container
FFPP3
E0869
Apheresis Fresh FROZEN PLASMA|ACD-A/XX/<=-18C|Open|3rd container
E0797
Thawed FRESH FROZEN PLASMA|CP2D/XX/refg
E1237
Thawed Apheresis FRESH FROZEN PLASMA|ACD-A/XX/refg
E0773
Thawed FRESH FROZEN PLASMA|CPD/XX/refg
E5275
Pooled Thawed Plasma, Frozen Within 24 Hours After Phlebotomy, from CPD Whole Blood
E5298
Pooled Thawed FFP from CPD Whole Blood
E5308
Pooled Thawed Plasma
E5309
Pooled Thawed Fresh Frozen Plasma
E6097
Pooled Thawed FFP, from ACD-A Apheresis
GR*
E3676
Apheresis GRANULOCYTES|NaCitrate-HES/XX/rt|Open
GRI*
E3677
Apheresis GRANULOCYTES|NaCitrate-HES/XX/rt|Open|Irradiated
DGAP*
E2528
PLASMA|CPD/XX/<=-18C
DGAP2D*
E2592
PLASMA|CP2D/XX/<=-18C
DGAPA1*
E2560
PLASMA|CPDA-1/XX/<=-18C
FFPP4
E0869
Apheresis Fresh FROZEN PLASMA|ACD-A/XX/<=-18C|Open|4th container
FFPP5
E0869
FFPP6
E0869
E0900
E0900
Apheresis Fresh FROZEN PLASMA|ACD-A/XX/<=-18C|>=200mL <400mL
E4689
Apheresis Fresh FROZEN PLASMA|ACD-A
E4693
E4697
Rev. June 2015
Memorial Blood Centers Testing
Testing Catalog
Viral Screening, Red Cell Typing, Nucleic Acid Testing
MBC.ORG/Products-and-Testing-Services/Products-and-Testing-Services-RelatedDocs
MBC Testing Catalog
Hepatitis B Virus
Hepatitis B Virus Surface Antigen
(HBsAg)
Specimen Requirements:
Glass Tubes
• Serum
• Plasma (EDTA, sodium heparin, sodium citrate, CPDA-1 and ACD anticoagulants)
Plastic Tubes
• Serum, serum separator tubes
• Plasma (EDTA, lithium heparin, and sodium citrate)
Cadaveric - serum (glass or plastic)
NOTE: Specimens collected with an improper ratio of specimen to anticoagulant can not be used for testing.
Specimen Volume:
(excluding the red cell
volume)
1.5 ml
Storage Instructions:
•
•
•
Shipping Requirements:
Ship at ambient temperature (up to 37ºC) or refrigerated (2-8ºC) for up to 7 days, and upon arrival should be
stored at 2-8ºC. For transit times greater than 7 days, the serum or plasma must be removed from the clot or
red blood cells and should be kept frozen, (≤ -20ºC).
Days Set Up:
Monday thru Saturday
CPT Code:
87340
Glass Tubes
• Serum
• Plasma (EDTA, sodium heparin, sodium citrate, CPDA-1 and ACD anticoagulants)
Plastic Tubes
• Serum, serum separator tubes
• Plasma (EDTA, lithium heparin, and sodium citrate)
Cadaveric - serum (glass or plastic)
Specimen Volume:
volume)
1.0 ml
•
•
•
Ship at ambient temperature (up to 37ºC) or refrigerated (2-8ºC) for up to 7 days, and upon arrival should be
stored at 2-8ºC. For transit times greater than 7 days, the serum or plasma must be removed from the clot or
red blood cells and should be kept frozen, (≤ -20ºC).
Days Set Up:
Monday/Tuesday, Wednesday, Friday
CPT Code:
87341
Test Code(s):
HBsAg - Neutralization performed on Repeat Reactive
samples
HBsAg (No Reflex) – No further testing performed
Manufacturer:
BioRad
Methodology:
EIA Screening
Hepatitis B Virus Surface Antigen
Neutralization
(HBsAg Confirmatory)
Test Code:
HBsAg Neutralization
Manufacturer:
BioRad
Methodology:
EIA Confirmatory
2-8ºC for 7 days
≤ -20ºC after 7 days (specimens should be removed from the clot or red blood cells prior to freezing)
5 Freeze/Thaw cycles
2-8ºC for 7 days
≤ -20ºC after 7 days (specimens should be removed from the red blood cells prior to freezing)
CONFIDENTIAL/PROPRIETARY: Distribution outside company with permission only.
IBR-JOB-AID-Org DT Job Aid-0030.02
Innovative Blood Resources, St. Paul, MN / Memorial Blood Centers / Nebraska Community Blood Bank
Page 1 of 17
08/2015
MBC Testing Catalog
Hepatitis B Virus – continued
• Serum
• Plasma (EDTA or NA and LI heparin)
• Do not use hemolyzed or heat-inactivated specimens
Specimen Volume:
volume)
100 µl
•
•
•
•
•
Specimens should be removed from the red blood cells and shipped frozen.
Days Set Up:
Monday thru Friday
CPT Code:
86317
• Serum
• Plasma (EDTA, heparin or citrate-based anticoagulants)
Specimen Volume:
volume)
0.5 ml
Anti-HBc Total
Manufacturer:
Ortho Clinical Diagnostics
•
•
•
Methodology:
EIA Screening
Specimens may be shipped at ambient temperature (up to 37ºC) or refrigerated (2-8ºC) for up to six days,
and upon arrival should be stored at 2-8ºC. For transit times greater than six days, the serum or plasma
must be removed from the clot or red blood cells and should be kept frozen, (≤ -20ºC).
Days Set Up:
CPT Code:
86704
Antibody to Hepatitis B Virus
Surface Antigen
(Anti-HBs)
Sent to ViroMed for testing
Test Code:
ADVIA Centaur Anti-HBs
Manufacturer:
ADVIA Centaur
Methodology:
Direct, chemiluminometric technology
Antibody to Hepatitis B Core
Antigen, Total
(Anti-HBc Total)
Test Code:
Specimens should be removed from the cells within 2 hours from collection.
8 hours at Room Temperature (15-28ºC)
2-8ºC for 3 days
≤ -20°C after 3 days (specimens should be removed from the red blood cells prior to freezing)
Avoid Multiple Freeze/Thaw cycles
2-8ºC for 7 days
Page 2 of 17
08/2015
MBC Testing Catalog
Hepatitis B Virus – continued
Antibody to Hepatitis B Core
Antigen IgM
(Anti-HBc IgM)
Test Code:
IMMULITE Anti-HBc IgM
• Serum
• Plasma (EDTA) Do not use hemolyzed or heat-inactivated specimens
Specimen Volume:
volume)
1.0 ml
•
•
•
•
•
Specimens should be removed from the cells prior to shipping. Specimens may be shipped at 2-8ºC for up
to 3 days; and upon arrival should be frozen at ≤ -20°C. For transit times greater than 3 days, the specimen
should be kept frozen at ≤ -20°C.
Days Set Up:
Sunday thru Friday
CPT Code:
86705
Manufacturer:
IMMULITE 2000
Methodology:
Immunochemiluminometric assay (ICMA)
2 days at Room Temperature (15-28ºC)
2-8ºC for 3 days
-20ºC after 3 days (specimens should be removed from the red blood cells prior to freezing)
Specimens which are not tested with in 24 hours should be removed from the cells
Page 3 of 17
08/2015
MBC Testing Catalog
Hepatitis C Virus
Antibody to Hepatitis C Virus
(Anti-HCV)
Test Code(s):
Anti-HCV - Repeat Reactive samples sent out for a
PRISM HCV
Anti-HCV (No Reflex) - No further testing performed
Manufacturer:
• Serum, SST
• Plasma (EDTA, lithium heparin, CPD, CP2D, CPDA-1, ACD or 4% citrate anticoagulants)
• Cadaveric - Serum, SST or EDTA tubes
Specimen Volume:
volume)
1.0 ml
•
•
•
Specimens may be shipped at ambient temperature (up to 37ºC) or refrigerated (2-8ºC) for up to seven days,
and upon arrival should be stored at 2-8ºC. For transit times greater than seven days, the serum or plasma
must be removed from the clot or red blood cells and should be kept frozen, (≤ -20ºC)
Days Set Up:
CPT Code:
86803
•
•
Specimen Volume:
volume)
1.0 ml
•
•
Specimens may be shipped at 30ºC or colder for a period not to exceed 7 days. If shipping the sample
frozen, remove the serum or plasma from the clot or red blood cells prior to shipping.
Days Set Up:
CPT Code:
86803
Methodology:
EIA Screening
(Anti-HCV)
Alternate Methodology
Sent to Indiana Blood Center for testing
Test Code:
PRISM HCV
Manufacturer:
Abbott Laboratories
Methodology:
Abbott PRISM HCV (ChLIA)
2-8ºC for 10 days
≤ -20ºC after 10 days (no longer than 4 weeks; specimens should be removed from the red blood cells
prior to freezing)
Serum, SST
Plasma (EDTA, potassium oxalate, sodium citrate, ACD-A, ACD-B, CP2D, CPD, or CPDA-1
anticoagulants or collected from segmented tubing)
• Cadaveric – Serum
2-8ºC for 14 days
Page 4 of 17
08/2015
MBC Testing Catalog
Human Immunodeficiency Virus (HIV)
• Serum, SST
• Plasma (EDTA, sodium & lithium heparin, sodium citrate, CPD, CPDA-1, and ACD)
• Cadaveric - Serum
Specimen Volume:
volume)
600ul
•
•
•
Specimens may be shipped refrigerated (2-8ºC) or at ambient temperature (≤37 ºC) for up to 7 days. For
shipments that are in transit for more than 7 days, the serum or plasma must be removed from the clot or red
blood cells and should be kept frozen, (≤ -20ºC).
Days Set Up:
Methodology:
EIA Screening
CPT Code:
86703
Antibody to Human
Immunodeficiency Virus Type 2
(Anti-HIV-2)
• Serum
• Plasma
Specimen Volume:
volume)
200 µl
•
•
•
Specimens may be shipped refrigerated (2-8ºC) for up to 7 days. For transit times greater than 7 days, the
serum or plasma must be removed from the clot or red blood cells and kept frozen, (≤ -15ºC).
Days Set Up:
CPT Code:
86702
Antibody to Human
Immunodeficiency Viruses Type 1
and 2 plus O
(Anti-HIV-1,2+O)
Test Code(s):
Anti-HIV-1,2 plus O – Western Blot performed on
Repeat Reactive samples
Anti-HIV-1,2 plus O (No Reflex) – No further
testing performed
Manufacturer:
BioRad
Test Code(s):
Anti-HIV-2 – HIV-2 Immunoblot performed on Repeat
Reactive samples
Anti-HIV-2 (No Reflex) – No further testing
performed
Manufacturer:
BioRad
Methodology:
EIA Screening
2-8ºC for 7 days
2-8ºC for 7 days
Page 5 of 17
08/2015
MBC Testing Catalog
Human Immunodeficiency Virus (HIV) – continued
Antibody to Human
Western Blot
(HIV-1 Western Blot)
Test Code:
• Serum
• Plasma (EDTA, heparin, sodium citrate, CPDA-1, and ACD)
Specimen Volume:
volume)
100 µl
HIV-1 Western Blot
Manufacturer:
BioRad
Methodology:
BioRad – Western Blot
Antibody to Human
Immunoblot
(HIV-2 Immunoblot)
Test Code:
HIV-2 Immunoblot
Manufacturer:
Laboratory developed assay using analyte
specific reagents
•
•
•
2-8ºC for 7 days
Specimens may be shipped refrigerated (2-8ºC) or at ambient temperature (≤37 ºC) for up to 7 days. For
shipments that are in transit for more than 7 days, the serum or plasma must be removed from the clot or red
blood cells and should be kept frozen, (≤ -20ºC).
Days Set Up:
CPT Code:
86689
• Serum
• EDTA Plasma
NOTE: Specimens collected with an improper ratio of specimen to anticoagulant can not be used for testing
Specimen Volume:
volume)
100 µl
•
•
Specimens may be shipped refrigerated (2-8ºC) for up to 7 days. For shipments that are in transit for more
than 7 days, the serum or plasma must be removed from the clot or red blood cells and should be kept
frozen, (≤ -20ºC).
Days Set Up:
Tuesday, Thursday, Saturday
CPT Code:
86689
2-8ºC for 7 days
Page 6 of 17
08/2015
MBC Testing Catalog
Human T-Lymphotropic Virus (HTLV)
Antibody to Human T-Lymphotropic
Virus Type I and II
(Anti-HTLV I/II)
Test Code(s):
Avioq HTLV-I/II - Repeat Reactive samples sent out
for a PRISM HTLV-I/II
• Serum, SST
• Plasma (EDTA, heparin, citrate, CPD, CPDA-1 anticoagulants or collected from segmented tubing)
Specimen Volume:
volume)
0.5 ml
•
•
•
Specimens may be shipped at ambient temperature, refrigerated (2-8ºC) or frozen (≤ -20ºC). Prior to
freezing, serum or plasma must be removed from the clot or red blood cells.
Days Set Up:
CPT Code(s):
86687 / 86688
•
•
Specimen Volume:
volume)
1.0 ml
•
•
Specimens may be shipped at 30ºC or colder for a period not to exceed 7 days if removed from clot or cells.
Prior to freezing, serum or plasma must be removed from the clot or red blood cells.
Days Set Up:
CPT Code(s):
86687 / 86688
Avioq HTLV-I/II (No Reflex) – No further testing
performed
Manufacturer:
Avioq
Methodology:
EIA Screening
Virus Type I and II
(Anti-HTLV I/II)
Test Code:
PRISM HTLV-I/II
Manufacturer:
Abbott Laboratories
Methodology:
Abbott PRISM HTLV-I/II (ChLIA)
2-8ºC for 14 days
1 Freeze/Thaw cycle
Serum, SST
2-8ºC for 14 days
Page 7 of 17
08/2015
MBC Testing Catalog
Human T-Lymphotropic Virus (HTLV) – continued
Virus Type I and II Immunoblot
(HTLV I/II Immunoblot)
• Serum, SST
• Plasma (EDTA, heparin, citrate anticoagulants)
Specimen Volume:
volume)
0.5 ml
HTLV-I/II Immunoblot
•
•
•
Manufacturer:
Innogenetics
Specimens may be shipped refrigerated (2-8ºC) for up to 7 days, or frozen (≤ -20ºC). Prior to freezing, serum
or plasma must be removed from the clot or red blood cells.
Days Set Up:
Tuesday, Thursday
CPT Code:
86689
Test Code:
Methodology:
Line Blot
2-8ºC for 7 days
3 Freeze/Thaw cycle
RUO - Research use only, not for diagnostic purposes
Page 8 of 17
08/2015
MBC Testing Catalog
Trypanosoma cruzi (T.cruzi)
Antibody to Trypanosoma cruzi
(Anti-T.cruzi)
Test Code(s):
Anti-T.cruzi - Repeat Reactive samples sent out for a
PRISM Chagas
Anti-T.cruzi (No Reflex) - No further testing
• Serum, SST
• Plasma (EDTA, lithium heparin, CPD, CP2D, CPDA-1, ACD or 4% citrate anticoagulants)
• Cadaveric – Serum, SST or EDTA
Specimen Volume:
volume)
1.0 ml
•
•
•
•
Specimens may be shipped at ambient temperature (up to 37ºC) or refrigerated (2-8ºC) for up to 7 days, and
upon arrival should be stored at 2-8ºC. For transit times greater than seven days, the serum or plasma must
be removed from the clot or red blood cells and should be kept frozen, (≤ -20ºC).
Days Set Up:
CPT Code:
86753
Serum, SST
• Cadaveric – Serum only
Specimen Volume:
volume)
1.0 ml
•
•
Specimens may be shipped at 30ºC or colder for up to 7 days, or 2-8°C or -20°C or colder for up to 14 days.
Prior to freezing, serum or plasma must be removed from the clot or red blood cells.
Days Set Up:
CPT Code:
86753
performed
Manufacturer:
Methodology:
EIA Screening
Antibody to Trypanosoma cruzi
(Anti-T.cruzi)
Test Code:
PRISM Chagas
Manufacturer:
Abbott Laboratories
Methodology:
Abbott PRISM Chagas (ChLIA)
Up to 37ºC for 24 hours
2-8ºC for 10 days
≤ -20ºC after 10 days up to 4 weeks (Can be stored for 6 months with 1 freeze/thaw cycle)
•
•
30ºC or colder for up to7 days
2-8ºC or -20ºC or colder for up to, but may not exceed, 14 days (specimens should be removed from the
red blood cells prior to freezing)
Page 9 of 17
08/2015
MBC Testing Catalog
Serologic Test for Syphilis (STS)
NEO Treponema Pallidum System
for detection of Syphilis
(Syphilis TPHA)
Test Code(s):
Syphilis TPHA – Syphilis MHA-TP performed on
repeat reactive samples
• Serum
• Plasma (EDTA)
Specimen Volume:
volume)
2.0 ml
•
•
Syphilis TPHA (No Reflex) - No further testing
performed
Manufacturer:
Immucor
Methodology:
Hemagglutination
•
1-10ºC for 7 days
≤ -20ºC after 7 days (specimens should be removed from the clot or red blood cells prior to
freezing)
Specimens may be shipped refrigerated (1-10ºC) for up to 7 days, or frozen (≤ -20ºC). Prior to freezing,
serum or plasma must be removed from the clot or red blood cells.
Days Set Up:
**Primary method for Non-Blood Donors**
PK Treponema Pallidum System for
detection of Syphilis
(Syphilis MHA-TP)
Test Code:
Syphilis MHA-TP
CPT Code:
Specimen Volume:
volume)
2.0 ml
•
•
•
Serum should be removed from the clot or red blood cells within 5 days from collection and ship frozen.
Days Set Up:
CPT Code:
86780 – STS – Treponema Pallidum
86780 – FTA-ABS
Note: On Blood Donor samples (and when this assay is
used as a backup for the NEO), a Syphilis TPHA is
performed on repeat reactive samples
Manufacturer:
Beckman Coulter
86780 – STS – Treponema Pallidum
• Plasma (EDTA)
• Serum
NOTE: Specimens collected with an improper ratio of specimen to anticoagulant cannot be used for testing.
2-8ºC - up to 5 days
Avoid repeat Freeze/Thaw cycles
Methodology:
Microhemagglutination
**Primary method for Blood Donors**
Page 10 of 17
08/2015
MBC Testing Catalog
Serologic Test for Syphilis (STS) – continued
Fluorescent Treponemal Antibody
Absorption Test
(FTA-ABS)
Test Code:
Syphilis FTA-ABS
Manufacturer:
MarDX
•
Specimen Volume:
1.0 ml
•
•
•
Specimen should be removed from the clot within 5 days from collection and ship frozen.
Days Set Up:
Monday thru Friday
CPT Code:
86780 – FTA-ABS
•
Specimen Volume:
volume)
0.5 ml
•
•
•
Serum should be removed from the clot or red blood cells within 5 days from collection and ship frozen.
Days Set Up:
Daily
CPT Code:
86592 – RPR
Serum
Methodology:
Indirect Fluorescent Antibody (IFA)
Rapid Plasma Reagin
(RPR)
Test Code:
Syphilis RPR
Manufacturer:
BD Macro-Vue
Methodology:
Charcoal Flocculation
Serum
Page 11 of 17
08/2015
MBC Testing Catalog
Nucleic Acid Testing (NAT)
COBAS TaqScreen MPX Test
(HIV/HCV/HBV PCR)
Test Code(s):
MPX – sent out for discriminatory testing by HIV-PCR,
MPX
HCV-PCR, and HBV-PCR if reactive.
(No Reflex) – no discriminatory testing
performed
This test is for the eligibility determination of Donors of
blood and blood components and human cells, tissues and
cellular tissue based products (HCT/Ps).
This test is not intended to be used for routine clinical or
diagnostic evaluation.
Manufacturer:
Roche
Methodology:
Roche RNA Polymerase Chain Reaction
COBAS AmpliScreen HIV-1, HCV,
HBV Individual Tests
(HIV-PCR/HCV-PCR/HBV-PCR)
Test Code(s):
HIV PCR
HCV PCR
HBV PCR
This test is performed individually. It is used as the
discriminatory testing if the MPX test is reactive.
Manufacturer:
Roche
Methodology:
• Plasma (EDTA*, CPD, CPDA-1, CP2D, ACD-A and 4% Sodium Citrate)
*EDTA is the recommended specimen, the other anticoagulants have more stringent storage
requirements that are difficult to comply with when shipping specimens for testing. Please call the
lab for the requirement if needed.
Specimen Volume:
1 full 7 ml EDTA plasma tube
EDTA only
Specimens should be removed from the red blood cells prior to freezing.
• 2-30ºC for 72 hours
• 2-8ºC for 5 days
• 2-8ºC for days 6-12 if separated from cells
• ≤ -18ºC for days 12-30
• 3 Freeze/Thaw cycles
EDTA plasma samples should be shipped within the storage specifications.
Days Set Up:
CPT Code(s):
HIV PCR – 87535
HCV PCR – 87521
HBV PCR – 87516
• Plasma (EDTA*, CPD, CPDA-1, CP2D, ACD-A and 4% Sodium Citrate)
Specimen Volume:
volume)
1.0 ml for 1 test or 2.0 ml’s for 2-3 tests
EDTA only
• 2-8ºC for 5 days
• ≤ -18ºC for days 12-30
Days Set Up:
CPT Code(s):
HIV PCR – 87535
HCV PCR – 87521
Page 12 of 17
08/2015
MBC Testing Catalog
HBV PCR – 87516
Nucleic Acid Testing (NAT) - continued
COBAS Taqscreen WNV Test
(WNV PCR)
Test Code:
WNV PCR
This test is for the eligibility determination of Donors of
blood and blood components.
• Plasma (EDTA*, CPD, CPDA-1, CP2D, ACD-A and 4% Sodium Citrate).
Specimen Volume:
EDTA only
• 2-30ºC for 24 hours followed by 24 hours at 2-25 ºC OR 2 days at 2-25 ºC
• 2-8ºC to 5 days
• ≤ -20ºC for days 12-30
Days Set Up:
CPT Code:
87798
Manufacturer:
Roche
Methodology:
Page 13 of 17
08/2015
MBC Testing Catalog
Cytomegalovirus (CMV)
Antibody to Cytomegalovirus
(Anti-CMV Total(IgG+IgM Antibody))
Serum – Samples collected in a tube containing a neutral gel separator are NOT acceptable.( False
positive results may occur.)
• Plasma (EDTA, ACD, CPD, CPDA-1 or CP2D)
•
Specimen Volume:
volume)
1.0 ml
•
•
•
•
Samples should be shipped within the storage specifications.
Days Set Up:
Immucor Capture-CMV – solid phase – automated
CPT Code:
86644
Cytomegalovirus IgM Antibody
(Anti-CMV IgM)
•
0.5 ml
Test Code:
Specimen Volume:
volume)
CMV IgM EIA
The serum should be removed from the clot.
• ≤ -20ºC after 48 hours
• Avoid multiple Freeze/Thaw cycles
Samples should be shipped within the storage specifications.
Days Set Up:
Monday, Wednesday, Friday
CPT Code:
86645
Test Code(s):
Capture-CMV Total (IgG / IgM Reflex) – CMV
IgG and CMV IgM are performed on reactive samples
Capture-CMV Total (IgM Reflex) – CMV IgM is
performed on reactive samples
Capture-CMV Total (No Reflex) – No further
testing is performed
Manufacturer:
Immucor
Methodology:
Manufacturer:
BioRad
Methodology:
EIA
1-10ºC for 7 days (Serum, EDTA, ACD, CPD)
1-10ºC for 42 days as whole blood (CPDA-1, CP2D)
Avoid repeat Freeze/Thaw cycles
Serum
Page 14 of 17
08/2015
Memorial Blood Centers Testing
Hepatitis B Virus
Hepatitis B Virus Surface
Antigen (HBsAg)
Test Code:
HBsAg
(Neutralization performed on Reactive
samples for confirmation)
• Serum
• Plasma (EDTA, sodium & lithium heparin, sodium citrate, CPDA-1
and ACD anticoagulants)
• Cadaveric serum specimen
Specimen Volume:
3 ml
• 2–8º C for 7 days
• ≤ -20º C after 7 days
Ship at ambient temperature (up to 37º C) or refrigerated (2–8º C) for
up to 7 days, and upon arrival should be stored at 2–8º C. For transit
times greater than 7 days, the specimens should be kept frozen
(≤ -20º C).
Days Set Up:
Monday through Saturday
CPT Code:
87340
• Serum
• Plasma (EDTA, sodium & lithium heparin, sodium citrate, CPDA-1
and ACD anticoagulants)
• Cadaveric serum specimen
Specimen Volume:
2 ml
Specimens may be shipped at ambient temperature (up to 37º C)
or refrigerated (2–8º C) for up to 7 days, and upon arrival should
be stored at 2–8º C. For transit times greater than 7 days, the
specimens should be kept frozen (≤ -20º C).
Days Set Up:
Tuesday, Thursday and Friday
CPT Code:
87341
Methodology:
BioRad – EIA Screening
Hepatitis B Virus Surface
Antigen Neutralization
(HBsAg Neutralization)
Test Code:
HBsAg Neutralization
Methodology:
BioRad – EIA
Rev. June 2015
Memorial Blood Centers Testing Catalog • Page 31
Hepatitis B Virus continued
Antibody to Hepatitis B Virus Specimen Requirements:
Surface Antigen Quantitation
(Anti-HBs)
• Serum
• Plasma (EDTA or heparin)
• Do not use hemolyzed or heat-inactivated specimens
Sent to ViroMed for Testing
Specimen Volume:
100 μl
Test Code: Anti-HBs
• Room Temp for 2 days
• ≤ -20° C after 3 days
• Multiple Freeze/Thaw cycles not recommended
Shipping conditions not specified
Days Set Up:
Monday through Friday
CPT Code:
86317
• Serum
Specimen Volume:
600 μl
or refrigerated (2–8º C) for up to six days, and upon arrival should
be stored at 2–8º C. For transit times greater than six days, the
Days Set Up:
CPT Code:
86704
Methodology: Immulite 2000 — Chemiluminescent EIA
Antibody to Hepatitis B
Core Antigen, Total
(Anti-HBc Total)
Test Code: Anti-HBc Total
Methodology: Ortho Clinical
Diagnostics — EIA Screening
Detects IgG and IgM antibodies.
No additional testing required for
confirmation of a Reactive sample.
Hepatitis B Virus e (envelope) Specimen Requirements:
Antigen (HBeAg)
Test Code: HBeAg
Serum — non hemolyzed
Specimen Volume:
1 ml
• 2–8º C for 48 hours
• ≤ -20º C after 48 hours
• 1 Freeze/Thaw cycle
Samples should be shipped on wet or dry ice depending on
previously stated storage requirements.
Days Set Up:
Monday
CPT Code:
87350
Methodology: Diasorin — EIA
Rev. June 2015
Hepatitis B Virus continued
Antibody to Hepatitis B
virus e Antigen (Anti-HBe)
Serum — non hemolyzed
Specimen Volume:
600 μl
Test Code: Anti-HBe
• 2–8º C for 48 hours
• ≤ -20º C after 48 hours
Samples should be shipped on wet or dry ice depending on
previously stated storage requirements.
Days Set Up:
Monday
CPT Code:
86707
(Anti-HCV)
• Serum
Test Code: Anti-HCV
(RIBA performed on Reactive samples for
confirmation)
or
Anti-HCV — No Reflex
(No RIBA is performed if sample is
Reactive)
Specimen Volume:
700 μl — Anti-HCV
600 μl — Anti-HCV — No Reflex
or refrigerated (2–8º C) for up to six days, and upon arrival should
be stored at 2–8º C. For transit times greater than six days, the
Days Set Up:
CPT Code:
86803 — Anti-HCV
86803 — Anti-HCV — No Reflex
Recombinant Immunoblot
Assay (RIBA) for Antibody to
Hepatitis C Virus (RIBA)
• Serum
• Plasma (K3EDTA, sodium heparin, ACD, CPDA-1, or 4% sodium
citrate)
Test Code: RIBA
Specimen Volume:
500 μl
Methodology: Chiron — SIA — v. 3.0
• Avoid multiple Freeze/Thaw cycles
Specimens may be shipped at ambient temperature (up to 37º C) or
refrigerated (2–8º C) for up to seven days, and upon arrival should
be stored at 2–8º C. For transit times greater than seven days, the
specimens should be kept frozen
(≤ -20º C).
Days Set Up:
Tuesday, Thursday
CPT Code:
86804
Methodology: Diasorin — EIA
Hepatitis C Virus
Methodology: Ortho Clinical
Diagnostics — EIA Screening
Human Immunodeficiency Virus (HIV)
Rev. June 2015
Human Immunodeficiency Virus (HIV) continued
BioRad Antibody to Human
Immunodeficiency Virus
Type 1 rLAV EIA (Anti-HIV-1)
• Serum
• Plasma (EDTA, heparin, sodium citrate, CPDA-1, and ACD)
Specimen Volume:
600 μl
Test Code: Anti-HIV-1
(Western Blot performed on Reactive
Methodology: BioRad — EIA — viral
lysate and E. coli recombinant antigen
Specimens may be shipped refrigerated (2–8º C) or at ambient
temperature for up to 7 days. For shipments that are in transit for
more than 7 days, specimens should be kept frozen (≤ -20º C).
Days Set Up:
Wednesday
CPT Code:
86701
• Serum (Cadaveric serum is also acceptable)
• Plasma (EDTA, sodium & lithium heparin, sodium citrate, CPD,
CPDA-1, and ACD)
Specimen Volume:
1 ml
more than 7 days, specimens should be kept frozen (≤ -20º C).
Days Set Up:
CPT Code:
86703
• Serum
• Plasma
Specimen Volume:
600 μl
• Freeze/Thaw cycles not specified
Days Set Up:
Wednesday
CPT Code:
86702 — Anti-HIV-2
86689 — HIV-2 Immunoblot
Antibody to Human
Immunodeficiency Viruses
Type 1 and 2 plus O
(Anti-HIV-1/2 + O)
Test Code: Anti-HIV-1,2
(Western Blot performed on Reactive
Methodology: BioRad — EIA screening
Antibody to Human
Type 2 (Anti-HIV-2)
Test Code: Anti-HIV-2
or
Anti-HIV-2 — Reflex
(Sent to ViroMed for an HIV2 Immunoblot if sample is
Reactive)
Methodology: BioRad — EIA
Rev. June 2015
Human Immunodeficiency Virus (HIV) continued
Antibody to Human
Type 1 Western Blot
(HIV-1 Western Blot)
• Serum
• Plasma
Specimen Volume:
500 μl
Test Code: HIV-1 Western Blot
more than 7 days, specimens should be kept frozen (≤ -20º C).
Days Set Up:
Wednesday and Friday
CPT Code:
86689 — HIV-1 WB
86689 — HIV-1 IFA
Methodology: BioRad — Western Blot
Note: Sent to Mayo Clinic for
HIV-1 IFA testing if the blot is
unreadable on 2 runs.
Antibody to Human Immunodeficiency Virus Type 1 Immuno Fluorscence Assay (HIV-1 IFA) — See HIV-1 Western Blot
Antibody to Human Immunodeficiency Virus Type 2 Immunoblot (Anti-HIV-2 Immunoblot) — See Anti-HIV-2
Human T-Lymphotropic Virus (HTLV)
Antibody to Human
T-Lymphotropic Virus Type I
and II (Anti-HTLV I/II)
Test Code: Anti-HTLV I/II
or
Anti-HTLV I/II — EIA Reflex
(Sent to LifeSource for
confirmation testing by Abbott
EIA if sample is Reactive.)
or
Anti-HTLV I/II — Donor Reflex
(Sent to ViroMed for HTLV
Immunoblot if sample is
Reactive.)
Methodology: Abbott Prism
chemiluminescent assay (CHLIA)
• Serum
• Plasma (EDTA, potassium oxalate, ACD, heparin, citrate,
CPD or CPDA-1 anticoagulants)
Specimen Volume:
500 μl
Specimens may be shipped ambient, refrigerated (2–8º C), or frozen
(≤ -20º C).
Days Set Up:
CPT Code:
86687/86688 — HTLV EIA Screen
86687/86688 — Alternate EIA Method Confirmation
86689 — HTLV I/II Immunoblot
Antibody to Human T-Lymphotropic Virus Type I and II Immunoblot (Anti-HTLV-I/II Immunoblot) — See Anti-HTLV I/II
Rev. June 2015
Trypanosoma cruzi (T.cruzi)
Antibody to Trypanosoma
cruzi (Anti-T.cruzi)
Test Code: Anti-T.cruzi
Sent to Quest for RIPA if
sample is Reactive
• Serum
• Plasma (EDTA, lithium heparin, CPD, CP2D, CPDA-1, ACD or 4%
citrate anticoagulants)
Specimen Volume:
600 μl
Specimens may be shipped ambient, refrigerated (2–8º C), or frozen
(≤ -20º C).
Days Set Up:
CPT Code:
86753 — T.cruzi EIA Screen
86753 — RIPA Confirmation
• Serum — Preferred
• Plasma (EDTA) — Acceptable
Specimen Volume:
1 mL (minimum 500 µl)
• ≤ -20º C after 10 days (up to 6 months)
Aliquot in a clean screw top vial. Specimens may be shipped
refrigerated (2–8º C) or frozen (≤ -20º C).
CPT Code:
86753 — RIPA Confirmation
Methodology: Ortho — EIA Screening
T.cruzi
Radioimmunoprecipitation
Assay (RIPA)
Sent to Quest Diagnostics for
testing
Set up Monday & Thursday
morning
Results in 12+ days
Methodology:
Radioimmunoprecipitation
Macro-Vue RPR Card Test for Specimen Requirements:
detection of Syphilis (Syphilis
RPR)
• Serum
• Plasma (EDTA, heparin, potassium oxalate, potassium sequestrene
or sodium fluoride
(if testing samples <24 hours old)
Test Code: Syphilis RPR
1.5 ml
Specimen Volume:
Sent to ViroMed for confirmation Storage Instructions:
by FTA-ABS if Reactive
Methodology: Latex Agglutination
• 2–8º C in original collecting tube
• ≤ -20º C
Days Set Up:
CPT Code:
86592 — STS
86781 — FTA-ABS
Rev. June 2015
Olympus PK Treponema
Pallidum System for
detection of Syphilis (Syphilis
Specimen Volume:
TP)
Test Code: Syphilis TP
Sent to ViroMed for confirmation
by FTA-ABS if Reactive
Methodology: Microhemagglutination
• Plasma (EDTA)
• Serum
1.5 ml
• 2–8º C — up to 5 days
• Avoid repeat Freeze/Thaw cycles
Shipping conditions not specified.
Days Set Up:
CPT Code:
86592 — STS
86781 — FTA-ABS
Rev. June 2015
Nucleic Acid Testing (NAT)
COBAS AmpliScreen HIV-1
and HCV Test (HIV/HCV PCR)
* EDTA is the recommended specimen, the other
anticoagulants have more stringent storage
requirements that are difficult to comply with when
shipping specimens for testing.
This test is for the eligibility determination
of donors of blood and blood components
and human cells, tissues and cellular
tissue based products (HCT/Ps).
This test is not intended to be used for
routine clinical or diagnostic evaluation.
Plasma (EDTA*, CPD, CPDA-1, CP2D, ACD-A and
4% sodium citrate).
Specimen Volume:
EDTA only
• 2–8º C for days 6–12 if separated from cells
• ≤ -18º C for days 15–30
Specimens may be shipped refrigerated (2-8ºC) or at ambient
temperature for up to 3 days. Specimens over 5 days old cannot be
tested unless they were centrifuged at
800–1600 × g for 20 minutes and removed from the cells. False
positive results can occur from cross contamination if samples are not
handled under a hood.
Days Set Up:
CPT Code:
HIV PCR — 87535
HCV PCR — 87521
Test Code: HIV/HCV PCR
Methodology: Roche RNA Polymerase
Chain Reaction
COBAS AmpliScreen HBV Test Specimen Requirements:
(HBV PCR)
4% Sodium Citrate).
of donors of blood and blood components
and human cells, tissues and cellular
tissue based products (HCT/Ps).
Specimen Volume:
EDTA only
• ≤ -18º C for days 15–30
temperature for up to 3 days. Specimens over 5 days old cannot be
tested unless they were centrifuged at
800–1600 × g for 20 minutes and removed from the cells. False
positive results can occur from cross contamination if samples are not
handled under a hood.
Days Set Up:
CPT Code:
87516
Test Code: HBV PCR
Methodology: Roche DNA Polymerase
Chain Reaction
Rev. June 2015
Nucleic Acid Testing (NAT) continued
COBAS Taqscreen WNV Test
(WNV PCR)
4% Sodium Citrate).
of donors of blood and blood
components.
Specimen Volume:
Test Code: WNV PCR
EDTA only
• ≤ -18º C for days 15–30
temperature for up to 3 days. Specimens over 5 days old can not be
tested unless they were centrifuged at 800–1600 × g for 20 minutes
and removed from the cells. False positive results can occur from
cross contamination if samples are not handled under a hood.
Days Set Up:
CPT Code:
87798
Methodology: Roche RNA Polymerase
Chain Reaction
Rev. June 2015
Quality Assurance
Physician Services and
Quality and Regulatory Affairs
Reporting Adverse
Outcomes of Transfusion
Memorial Blood Centers’ Physicians and Quality and
Regulatory Affairs staff are available to answer any
questions related to quality, regulations or transfusion
medicine in general. Our highly trained staff includes
physicians, specialists in blood banking, and medical
technologists. Several of Memorial Blood Centers staff
serve on committees, as board members or as assessors
for professional organizations such as AABB, America’s
Blood Centers (ABC), Foundation for the Accreditation
of Cellular Therapy (FACT), and National Marrow
Donor Program (NMDP). A physician is available for
consultation at all times and may be contacted through
Hospital Services during non-business hours.
Transfusion Services are required to have a
mechanism in place to document and track adverse
events related or potentially related to transfusion.
The Serious Outcome of Transfusion (SOOT) Report
and Suspected Transfusion Transmitted Disease
(TTD) Report are used to report these adverse events
to Memorial Blood Centers. Both forms are available
through Memorial Blood Centers’ physicians or their
designees in Physician Services. Current examples
of both forms are located on pages 43 and 44 of this
chapter. Forms can also be found on MBC.ORG/
Products-and-Testing-Services under Related Forms
& Docs.
Information on Memorial Blood Centers’ licensing
and accreditations are available at MBC.ORG/AboutUs/Accreditations.
Initial notification of a patient/recipient fatality
should be reported to the FDA as soon as possible by
the facility that performed the compatibility tests. A
written report of the investigation shall be submitted
to the FDA within seven days after the fatality. Please
see FDA Guidance for Industry on pages 48-54.
Quarantine, Market Withdrawal,
Recall, Inventory Lookback
and Recipient Notification
Occasionally Memorial Blood Centers will request
that you quarantine an in-date blood component if
it is still in your inventory. You will be notified by
phone and by fax of any in-date components that
need to be quarantined. If the component has already
been transfused, you will receive a letter if recipient
notification or tracing is necessary.
Immediate notification of the physician on call at
Memorial Blood Centers allows review of records
and supplies related to donor suitability, collection,
processing, storage and distribution of the
components.
It may be necessary for Memorial Blood Centers to
request the return of a unit of blood and/or blood
component that was issued to your facility. When
the safety, quality, purity, potency or identity of a
component may be affected, a market withdrawal or
recall letter will be sent directly to the physician in
charge of your Transfusion Service, indicating the
reason for the market withdrawal or recall.
If you are notified of a market withdrawal
or recall, it is imperative that you:
1. Immediately quarantine any in-date components
in inventory at your facility.
2. Complete necessary documentation and return to
Memorial Blood Centers as requested so we can:
• Verify that your facility received notification;
• Verify that your facility received the component
involved;
• Complete final disposition records as required
by FDA.
Rev. June 2015
Quality Assurance • Page 41
Communications
Customer Service Reports:
Memorial Blood Centers strives to provide excellent
customer service to each of our customers. We
are continuously seeking new ideas for ways to
improve or expand the services we provide. We
need your assistance to identify the areas where
we need improvement as well as the areas where
we are meeting or exceeding your expectations. To
gather your feedback, Memorial Blood Centers has
provided your facility with a supply of Customer
Service Reports (CSR). Please complete a CSR any
time a problem is identified or when excellent or poor
service is provided to your facility. Please include
as much detail as possible so that we can follow-up
appropriately.
Every CSR is reviewed by the responsible department
manager to determine appropriate action. These
events are tracked by the Quality and Regulatory
Affairs department to identify opportunities for
continuous process improvement.
Rev. June 2015
Quality Control (QC) of
Blood Components
Memorial Blood Centers performs quality control on
components in accordance with the requirements of
the AABB and the Food and Drug Administration
(FDA). A Blood Component QC Summary will be sent
to your facility monthly.
If you have questions about the Blood Component QC
Summary, please contact the manager of Component
Services at 651-332-7117.
Rev. June 2015
Rev. June 2015
Reference Laboratory
Request for Antibody
Identification and Red
Cell Crossmatching
1. Request products and testing using Memorial
Blood Centers Request for Reference Laboratory
Testing Form (sample on page 47). Form may be
found on MBC’s website at www.mbc.org.
2.Form MUST have patient identification
information, hospital name, the test requested and
the date and time needed. Specimen requirements
are on the reverse side of the form.
3. Samples must meet AABB labeling requirements.
Samples for crossmatching MUST have patient’s
first and last name, identification number, draw
date, and identity of phlebotomist.
4. Please send copies of any red cell panel results and
any other information to aid in testing, i.e. list of
medications, historical test results, etc.
5. Antibody identification is routinely performed
using polyethylene glycol (PEG) as an
enhancement media. If an institution indicates a
method of testing, we will do the first red cell panel
in the same media if available and time permits.
6. Hospitals will receive verbal reports from the
technologist upon completion of identification.
Final reports are usually available 1-2 business
days after completion of testing, and are faxed to
the hospital when completed. Preliminary reports
can be faxed upon request if the final report is not
available.
7. Patient red cell genotyping is available upon
request using the Memorial Blood Centers Request
for Reference Laboratory Testing Form.
Unit Antigen Typing
1. Antigen typing is performed on all antigen
negative units requested between 2:00 am Monday
through 11:00 pm Friday. Typed units are identified
with a white string tag identifying which antigens
have been confirmed as negative. STAT and ASAP
requests placed after 11:00 pm and before 7:00 am
will incur an additional STAT charge.
2. Local/Metro requests for antigen negative units
placed after-hours, 11:00 pm Friday–2:00 am
Monday, may be requested by the hospital to be
sent out with historical typing. It is the hospital’s
responsibility to confirm the antigen type on these
units.
3. The Reference Lab will confirm antigen typing on
units during after-hours if requested by a hospital
to do so. An after-hours service fee will be charged
to the hospital for this service.
Antibodies in Donors
When antibodies are detected in autologous donors,
the hospital will receive a report stating specificity.
The hospital will be charged for the cost of the red cell
panels performed on autologous donors. If a hospital
prefers to perform the antibody identification, policy
must be established prior to donation.
Platelet Crossmatching
Platelet crossmatching and HLA matched platelets
may be beneficial to refractory alloimmunized
patients with documented lack of response to pooled
random donor platelets and/or apheresis platelets.
1. Request products and testing using Memorial
Blood Centers Requests for Reference Laboratory
Testing Form (sample on page 47). Form may be
found on MBC’s website at www.mbc.org.
2. Form must have patient identification information,
hospital name, the test requested and the date and
time needed.
3. Samples must meet AABB labeling requirements.
Samples must have patient’s first and last name,
identification number, draw date, and identity of
phlebotomist.
4. Platelet crossmatching is performed at 12:00
p.m. Monday-Friday. Requests for crossmatched
platelets any other time will incur an additional
STAT charge.
Rev. June 2015
Reference Laboratory • Page 45
HLA Matched Platelets
1. If patient is refractory to crossmatched patients,
HLA matched platelets may be considered.
2. Patient HLA typing shall be requested using
Memorial Blood Centers Request for Reference
Laboratory Form.
3. Time to procure an HLA matched product for a
patient will vary based on HLA type. For donors
expecting ongoing transfusions, HLA matched
donors will be scheduled as available.
4. If Memorial Blood Centers does not have an
adequate match, other blood centers may be
contacted at the hospitals request. All charges
associated with imported products are passed on to
the requesting hospital.
5. Family donations may be considered if HLA
matches are not available.
Service Fees
1. Reference Lab has an on-call (AFHRS) and an
overnight (STAT) service charge. The on-call
charge applies to testing performed Friday 11:00
pm through Sunday 11:00 pm, and on holidays. The
STAT service charge applies to testing that must
be performed after 11:00 pm and before 7:00 am
Sunday through Thursday. This charge also applies
to platelet crossmatching performed any time other
than 12:00 pm
2. Coverage of weekends and holidays is provided by
an on-call technologist. He or she can be reached
by contacting Hospital Services (651-332-7108).
3. Requests for units negative for a high frequency
antigen or negative for multiple antigens that occur
in 5-percent or less of the population are assessed
an additional rare (RARE) or phenotyped unit
(PHUN) charge respectively.
4. Charges associated with importing rare blood from
other blood centers are passed on to the requesting
facility.
5. A Platelet Compatibility Charge is applied the
first time a patient is tested and after a period
of remission or if no crossmatched platelets are
ordered. A platelet crossmatch charge is applied to
each unit sent; double platelets are charged a single
crossmatch fee.
Rev. June 2015
Request for Reference Lab Testing
Request for
Reference Laboratory Testing
Lab Phone: ( 651) 332-7125
Lab Fax: ( 651) 332-7008
INSTRUCTIONS: Complete information must accompany each specimen. Identify each sample with patient’s first and last name,
identifying number and date drawn ( written in ink ). Improperly labeled specimens will not be processed.
Date_____________________________________________ When needed (date / time)________________________________
Hospital / Lab_______________________________________ City________________________________________________
State, Zip _________________________________________ Phone ( _____ ) _____________ Fax ( _____ ) ______________
TEST REQUESTED:
o Antibody Identification
oPlatelet Compatibility
o ABO and Rh typing
o Crossmatch:
o DAT and monospecific AHG
Number of units requested _________
o Elution study
o Antigen negative unit ( uncrossmatched ):
oABO, Rh and antibody screening
Number of units requested _________
o Red blood cells ( RBC )
oHDN evaluation–Mother and baby
oKleihauer-Betke test, type of specimen
o Leukocyte-reduced RBC
______________________________________________
o Platelets, Pheresis
Reason test ordered _______________________________
o Other, specify ___________________________________
oOther (specify) ________________________________________________________________________________________
___________________________________________________________________________________________________
__________________________________________________________________________________________________
PATIENT INFORMATION:
Patient’s name _________________________________________________ Date of birth ______________________ Sex____
( Please print )
Last
First
MI
Identifying number ______________________________________________ Date / time sample drawn ____________________
Clinical diagnosis________________________________________________________________________________________
Medications____________________________________________________________________________________________
TRANSFUSION HISTORY: oNo oYes, date of last and quantity ___________________________ oUnavailable
OBSTETRICAL HISTORY: EDC ______________________________________________________________________________
Pregnancy oNo oYes, indicate number and date of last _________________________________________________________
Has patient received Rh immune globulin in the past 6 months? oNo oYes, date received ________________________________
HISTORY OF PREVIOUS RED CELL ANTIBODY: oNo oYes, specificity ( ies ) ___________________________________________
DESCRIPTION OF REQUESTING FACILITY’S RESULTS:
Blood type ______________ DAT ______________ Auto control ______________ FMH screen ________________
Red cell antibody screening (circle phase of reaction, results and method used )
Reaction phase: RT 37C IAT
Reaction strength: 1+ 2+ 3+ 4+ micro
Method: saline albumin LISS PEG enzyme Gel card Other _____________________________________________
Red cell phenotype: C
E c e
K
M
N
S
s
Fy ( a b )
Jk ( a b )
Units crossmatched? oYes, Compatible ______________
Incompatible ______________
Request for
Reference Laboratory Testing
Quantity
FORM-RL-001.12 12-07
Quantity
This form should not be used when submitting hepatitis, HIV, HLA typing or parentage samples.
( 2-sided
document ) from specific laboratories.
Appropriate forms
are available
SPECIMEN REQUIREMENTS
________________________________________________________________________________________________________________________________________________________________________________________
TEST
SAMPLE REQUIRED
TEST
SAMPLE REQUIRED
________________________________________________________________________________________________________________________________________________________________________________________
ABO and Rh typing
5-10mL clotted blood
Elution study
7-10mL EDTA whole blood
________________________________________________________________________________________________________________________________________________________________________________________
Antibody screen / identification,
Compatibility testing
(red cell & platelet*)
10-20mL clotted blood**
or EDTA whole blood
HDN evaluation
Mom: 10mL clotted blood
Baby: 2-5mL cord blood
________________________________________________________________________________________________________________________________________________________________________________________
DAT with monospecific AHG
5-7mL EDTA whole blood
Kleihauer-Betke test
5mL EDTA whole blood
________________________________________________________________________________________________________________________________________________________________________________________
NOTE: Gel tubes are unacceptable as they can cause a false positive DAT.
*
Platelet crossmatch sample must be submitted within 48 hours of collection.
** If patient has a positive direct antiglobulin test (DAT), include a 7mL EDTA tube.
For recently transfused patients, include pretransfusion specimen if available.
All samples referred to Memorial Blood Centers for crossmatching and pretransfusion testing must meet the current Standards of the
AABB regarding recipient blood samples. Sender will be notified if a sample is unacceptable; a new sample will be required.
DIRECTIONS FOR SAMPLE TRANSPORT
MBC suggests shipping samples at ambient temperature unless temperatures are >82F or <32F.
If ambient temperature is >82F, ship samples with coolant.
If ambient temperature is <32F, ship samples in insulated container.
STAFFING HOURS
The Reference Laboratory is fully staffed from 11:00 P.M. Sunday through 11:00 P.M. Friday.
During these hours, contact the lab at (651) 332-7125 or (651) 332-7118.
For after-hours requests, call the blood center at (651) 332-7108 and ask for the Reference Lab on-call technologist.
737 Pelham Boulevard • St. Paul, MN 55114
Lab Phone ( 651) 332-7125
Lab Fax ( 651) 332-7008
FORM-RL-001.12 12-07
Rev. June 2015
( 2-sided document )
Notifying FDA of Fatalities Related to
Blood Collection or Transfusion
FINAL GUIDANCE
Additional copies of this guidance are available from the Office of Communication, Training and
Manufacturers Assistance (HFM-40), 1401 Rockville Pike, Rockville, MD 20852-1448, or by
calling 1-800-835-4709 or 301-827-1800, or from the Internet at
http://www.fda.gov/cber/guidelines.htm.
For questions on the content of this guidance contact Lois Simmons at 301-827-6220.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Biologics Evaluation and Research
September 2003
Rev. June 2015
Guidance for Industry • Page 48
Contains Nonbinding Recommendations
Table of Contents
I.
PURPOSE.............................................................................................................. 1
II.
BACKGROUND ................................................................................................... 1
III.
HOW TO NOTIFY FDA……………………………………………………….. 2
IV.
INITIAL NOTIFICATION…………………………………………………….. 2
A.
Patient/Recipient Fatalities ...................................................................... 3
B.
Donor Fatalities......................................................................................... 3
C.
Fatalities Associated with Therapeutic Apheresis or Certain
Therapeutic Phlebotomies........................................................................ 3
V.
7-DAY REPORT................................................................................................... 3
A.
Patient/Recipient Fatalities ...................................................................... 4
B.
Donor Fatalities......................................................................................... 4
C.
Fatalities Associated with Therapeutic Apheresis or Certain
Therapeutic Phlebotomies........................................................................ 5
VI.
INQUIRIES ........................................................................................................... 5
i
Rev. June 2015
Notifying FDA of Fatalities Related to Blood Collection or
Transfusion
This guidance represents the Food and Drug Administration’s (FDA’s) current thinking on this
topic. It does not create or confer any rights for or on any person and does not operate to bind
FDA or the public. You can use an alternative approach if the approach satisfies the
requirements of the applicable statutes and regulations. If you want to discuss an alternative
approach, contact the appropriate FDA staff. If you cannot identify the appropriate FDA staff,
call the appropriate number listed on the title page of this guidance.
I.
PURPOSE
This document’s goal is to help you, a blood collection or transfusion facility, report fatalities
related to blood and blood component (blood) collection or transfusion to us, the Food and Drug
Administration (FDA), Center for Biologics Evaluation and Research (CBER). This guidance
finalizes the draft guidance of the same title dated June 2002.
FDA’s guidance documents, including this guidance, do not establish legally enforceable
responsibilities. Instead, guidances describe the FDA’s current thinking on a topic and should be
viewed only as recommendations, unless specific regulatory or statutory requirements are cited.
The use of the word should in FDA’s guidances mean that something is suggested or
recommended, but not required.
II.
BACKGROUND
The current good manufacturing practice (CGMP) regulations for blood and blood components
require that you report fatalities related to blood collection or transfusion to CBER (21 CFR
606.170(b)). Section 606.170(b) states:
When a complication of blood collection or transfusion is confirmed to be fatal,
the Director, Office of Compliance and Biologics Quality, Center for Biologics
Evaluation and Research, shall be notified by telephone, facsimile, exp ress mail,
or electronically transmitted mail as soon as possible; a written report of the
investigation shall be submitted to the Director, Office of Compliance and
Biologics Quality, Center for Biologics Evaluation and Research, within 7 days
after the fatality by the collecting facility in the event of a donor reaction, or by
the facility that performed the compatibility tests in the event of a transfusion
reaction. (Emphasis added)
1
Rev. June 2015
Standard operating procedures for compatibility testing are required in 21 CFR 606.151
and 606.100(b)(8). Among other things, that regulation requires an establishment to have
procedures both for collecting and identifying the blood samples of recipients, and for
demonstrating incompatibility between the donor’s cell type and the recipient’s serum or
plasma type. CBER is aware that some blood banks and transfusion services may enter
into contracts with blood centers or other blood banks or clinical laboratories to perform
testing on blood samples. If this is how your facility operates, the responsibility for
compatibility testing is shared between the blood bank or transfusion service that collects
and identifies the blood sample of the recipient, and the blood center or other blood bank
or clinical laboratory that uses procedures to demonstrate incompatibility between the
donated blood product and the recipient. If a transfusion-related fatality occurs, both the
transfusing facility and the blood center or bank that performed the testing under contract
would be responsible for reporting the death to CBER. Under these circumstances, the
two facilities may make a joint report under § 606.170(b).
III.
HOW TO NOTIFY FDA
Section 606.170(b) states that you may report a fatality by telephone, facsimile, express mail, or
electronically transmitted mail (e- mail). We recommend that you submit the initial notification
by e- mail, if possible, and if you do so, you will receive an e-mail confirmation receipt from us.
If e- mail is not feasible, please notify us by telephone or facsimile. We cannot access
notification outside of customary working hours unless you use e-mail or telephone. Similarly,
we recommend that you submit 7-day follow up reports by e-mail, facsimile, or express mail.
•
•
•
•
IV.
E- mail: [email protected]
Telephone/voice-mail number: 301-827-6220
Fax number: 301-827-6748, Attn: CBER Fatality Program Manager
Express mail address:
Office of Compliance and Biologics Quality/CBER
Attn: Fatality Program Manager (HFM-650)
1401 Rockville Pike, Suite 200N
Rockville, MD 20852-1448
INITIAL NOTIFICATION
There is no required FDA form or format for notifying us of fatalities related to blood transfusion
or blood collection. We recommend that you provide at least the following information so we
can evaluate the potential public health significance of the event.
• Date and time of the notification.
• Your name, title, telephone number with area code, and fax number (if available).
• Your facility's name, mailing address, and FDA registration number (if applicable).
NOTE: Transfusion services that do not routinely collect or process blood or blood
components are not required to register with FDA and, therefore, do not usually have a
registration number.
2
Rev. June 2015
•
•
•
•
•
Age and sex of the deceased.
Date, time, and cause or suspected cause of death (briefly describe what happened).
If an autopsy was or will be performed.
Name and address of facility where the fatality occurred if different from your facility.
Please also include in the initial notification the information listed in A, B, or C below, as
appropriate:
A.
Patient/Recipient Fatality
- Transfusion date(s),
- Blood/blood component(s) and unit number(s) of product(s) that may be
implicated,
- Name and address of facility(ies) providing the blood, and
- Brief description of events that led to the fatality – include underlying medical
condition or disease and circumstances necessitating this hospitalization, reason
for transfusion, how the patient initially responded to the transfusion, any
medical intervention taken or response to the reaction, and time from initiating
the transfusion to patient’s death.
B.
Donor Fatality
- Collection date,
- What product was collected or attempted to be collected,
- Whether this was a manual or automated collection,
- If automated, the name and model of collection device and device manufacturer,
and
- Brief description of events that led to the fatality – include an overview of the
donor’s previous donations/health history, approximate frequency of donation,
any unusual events that occurred during this or any previous donation by the
donor, any medical intervention taken or response to the reaction, and time from
initiating the blood collection to donor’s death.
C.
Fatality Associated with Therapeutic Apheresis or Certain Therapeutic
Phlebotomies
- Date of therapeutic apheresis (e.g., therapeutic plasma exchange) or therapeutic
phlebotomy,
NOTE: A report is required for a therapeutic apheresis fatality only if blood
products (e.g., plasma, albumin), rather than products such as crystalloids or
hydroxyethyl starch, were given as part of the procedure. A report is required
for a therapeutic phlebotomy fatality only if a blood product was collected for
manufacture into transfusable biologics.
- Whether product was collected, and the product’s disposition,
- Whether this was a manual or automated collection (if automated, include
manufacturer, name, and model of collection device),
- If any blood product(s) was transfused, identify the product and the unit or lot
number(s), and
- Brief description of events that led to the fatality – include underlying medical
condition or disease and circumstances necessitating the therapeutic apheresis or
3
Rev. June 2015
therapeutic phlebotomy, any medical intervention or response to the reaction,
and time from initiating the procedure to patient’s death.
V.
7-DAY REPORT
You must submit a written report of the fatality investigation to CBER within 7 days after the
fatality (§ 606.170(b)). We recommend that you identify this report as a follow-up on a fatality
notification previously reported to CBER and include the initial notification date. We also
recommend that this 7-day report provide any new findings or information relevant to the fatality
that have become available since the initial notification, including your follow-up investigation
and conclusions.
Section 606.170(a) requires that you conduct a “thorough investigation” of adverse reactions
relating to blood collection or transfusion. Section 606.170(b) requires submission of a written
report of such investigation within 7 days after an adverse reaction resulting in fatality. We
recommend that a “thorough investigation,” and an associated written report for a fatality,
include:
• Discharge summary and/or death certificate,
• Autopsy report (if performed),
• Conclusions and follow-up actions (frequently referred to in the blood community as a
corrective action plan), if appropriate, and
• Either A, B, or C listed below, as appropriate.
We understand that, due to the complexity of some fatality investigations, some of this
information may not be available when you submit your 7-day report. In that event, you may
amend your 7-day report by filing additional information as it becomes available.
A.
Patient/Recipient Fatality
- Complete transfusion reaction report, including the manufacturer and lot number
of the blood collection system and results of the clerical, serological, and visual
re-checks performed.
- Additional relevant documents, include hematology reports; clinical chemistry
reports for cardiac and/or liver enzymes, albumin, and bilirubin; viral marker
tests; microbiology reports; reports of anti- HLA and/or anti-neutrophil antibody
testing; tryptase levels; radiology reports; and physicians’ consults/opinions.
- If replacement fluid(s) was given during the transfusion, indicate which fluid(s)
and the unit or lot number(s), and include any other relevant information,
manufacturer’s notices, contamination warnings, or replacement fluid recalls.
- If responsibility for the fatality appears to be outside the blood bank, the nurses’
and/or physicians’ notes on the patient, radiology reports, and physicians’
consults/opinions.
- Results of lookback investigation, including follow- up testing on implicated
donor(s) when the fatality was the result of transfusion transmitted infectious
disease such as hepatitis or HIV.
4
Rev. June 2015
- Meeting minutes or report from your transfusion committee when the fatality
was reviewed and discussed. If this incident was reviewed by any other hospital
oversight group(s) such as risk management or quality practices, include the
report or summary of their findings.
VI.
B.
Donor Fatality
- The deceased’s donor record file that includes the donation just before the fatal
incident and information on all donations during the past 2 years.
- Lot numbers and expiration dates of collection sets or harnesses; if replacement
fluid(s) was given during the collection, indicate which fluid(s) and the unit or
lot number(s) and include any other relevant information, such as
- Performance log for the device and any other relevant performance logs,
maintenance records, manufacturer’s notices, or recalls on significant machine
part(s) on the device/system during the past 2 years.
- If the donor was hospitalized due to the reaction, provide any relevant
documents, e.g., reports of laboratory tests, which may help determine the cause
of the fatality.
C.
Fatality Associated with Therapeutic Apheresis or Certain Thera peutic
Phlebotomies
- A summary of the deceased’s history of previous therapeutic apheresis or
therapeutic phlebotomy procedures, including any previous adverse reactions
related to the procedures.
- Lot numbers and expiration dates of collection sets or harnesses; if replacement
fluid(s) was given at any time during the procedure, indicate which fluid(s) and
the unit or lot number(s) and include any other relevant information, such as
- A summary of the performance log for the device and any other relevant
performance logs, maintenance records, and manufacturer’s notices or recalls on
any significant machine part(s) on the device/system during the past 2 years.
- If the fatality followed therapeutic plasma exchange (TPE) and Fresh Frozen
Plasma (FFP) was the replacement fluid, an abbreviated transfusion reaction
work-up to rule out ABO incompatibility, bacterial contamination, anaphylactic
reaction, or WBC antibody reaction may be useful.
INQUIRIES
If you have any questions about reporting fatalities, please contact the CBER Fatality Program
Manager at 301-827-6220.
5
Rev. June 2015
Qualifications Letter
June 1, 2013
Memorandum
To:
Memorial Blood Centers Customers
From:Quality and Regulatory Affairs Department
737 Pelham Boulevard
St. Paul, MN 55114
Re:
Vendor Qualifications
Memorial Blood Centers is licensed by the Food and Drug Administration (FDA) to manufacture blood
and blood components (Establishment License Number 1895) and is regularly inspected by the FDA.
Memorial Blood Centers follows the regulations contained in parts 600, 601, 606, 607, 610 and 640 of Title
21 of the Code of Federal Regulations and performs testing according to current Good Manufacturing
Practices (cGMPs). Memorial Blood Centers has a quality assurance unit in place, as required by the FDA.
Testing in the Donor Testing Laboratory is performed using FDA-licensed test kits, if such kits are
available. Tests are performed and interpreted according to the test-kit manufacturer’s instructions. Donor
samples tested for investigational assays are done with prior donor consent and prior approval by an IRB
(Institutional Review Board). Testing in the Immunohematology Reference Laboratory is performed using
a combination of FDA-licensed reagents and reagents prepared in-house. When FDA-licensed reagents are
used, the tests are performed and interpreted according to the manufacturer’s instructions. When reagents
are prepared in-house, the FDA requirements for potency, contained in 21 CFR Part 660, are followed.
Memorial Blood Centers laboratories are certified by the Centers for Medicare & Medicaid Services (CLIA
ID Number 24D0663800).
Memorial Blood Centers is also inspected and accredited by the American Association of Blood Banks
(Facility ID Number 6301). Copies of our FDA, AABB, and CLIA certificates are available at MBC.ORG.
If you would like specific information about our quality-control procedures, package inserts for test
reagents or Laboratory Medicine SOPs, please do not hesitate to contact QRA at the address above, or by
phone at 651-332-7000 or fax at 651-332-7001.
Rev. June 2015
Parentage Testing
Common Questions & Answers
Why should you choose
Memorial Blood Centers?
Memorial Blood Centers (MBC) is one of the oldest,
most respected names in parentage testing. We are
committed to providing excellent customer service
at affordable prices. We have been accredited by the
AABB (the national accreditation organization) since
1984. A reputation for reliability and a commitment
to education and research have set us apart from our
competitors.
How can I start testing for
a parentage dispute?
Appointments can be scheduled through our
customer service office at:
(612) 871-6636 or (800) 982-9134
To schedule an appointment, you must have the
following information:
• Names and birth dates of all parties involved in the
test.
• Approximate place, day and time you would like
your appointment to be scheduled.
What type of testing is available?
Paternity: In matters of paternity, specimens
are collected from the Mother, Child and Alleged
Father(s). It is possible to perform testing without
the mother. Motherless cases may require additional
testing time and are assessed a different fee.
Family Studies: Cases to determine maternity
and sibling relationships are also available. We can
also perform “family reconstruction” testing if an
individual is unavailable to be tested. We can do this
by testing the individual’s available family members.
Please contact our customer service office for fee
schedules and more information.
Immigration: Immigration paternity, maternity and
family studies are available. Test results can be sent
to U.S. Embassies worldwide or to U.S. Citizenship
and Immigration Services (USCIS) offices in the U.S.
Please contact our customer service office for fee
schedules and more information.
At what age are children able to be tested?
We are able to collect samples from children prior to
birth, at birth or after birth for parentage testing.
Amniotic Fluid or Chorionic Villi Sample: If you
would like to have testing performed before the
child is born, your doctor may perform either an
amniocentesis or a chorionic villi sampling. The
amniocentesis fluid or the chorionic villi sample can
be used to test with buccal cell samples collected from
the mother and alleged father to determine parentage
prior to birth. Please contact our customer service
office for fee schedule and more information.
Umbilical Cord Collection: If you know before the
child is born that you would like testing performed,
please contact our office. We advise at least a twoweek notice to ensure delivery of the collection kit on
time. Many hospitals will comply with this request;
however, some may elect not to participate. Please
discuss this option with the attending Doctor or
Midwife before delivery. The mother and alleged
father(s) should arrange to have samples collected at
our facility or at one of our collection sites.
Buccal Cell Collection: If cord blood is not collected,
the child may have a buccal cell collection performed.
This procedure involves swabbing the inside of the
baby’s cheeks with cotton swabs similar to those
used for throat cultures. Blood samples are no longer
required for DNA relationship testing.
What type of sample is collected
from the individuals tested?
Buccal Samples: Four swabs are collected by rubbing
two swabs on the inside each cheek for approximately
15 seconds.
Do not drink very hot liquid immediately preceding
sample collection.
Blood Samples: Blood samples are no longer required
for DNA relationship testing.
How long does the collection take?
Completing the forms and collecting the samples
takes about 15–30 minutes for the mother and child,
and about 15 minutes for the alleged father. You will
need to bring identification (preferably a photo id).
A photograph and thumbprint will be taken and a
consent form must be signed before your samples can
be collected.
Rev. June 2015
Parentage Testing • Page 56
Is there a difference in accuracy between
a blood and buccal swab sample?
Will the child and/or mother need to be
re-collected if the first man is excluded?
In an individual, the DNA is the same whether a
blood sample or a buccal swab sample is collected
and will provide identical results after testing. The
reliability of DNA testing is based on obtaining DNA
from nucleated cells, not from a specific source. The
DNA from an individual will be the same regardless
of whether it is extracted from blood or buccal cells.
The major difference in the types of sample collection
relates to ease of collection, stability of storage and
ease of use in the lab. Once the DNA has been
extracted, the testing procedures are the same for all
sample types.
In most cases, we would not need additional samples
from either the child or the mother.
Are these tests accurate?
Yes. A standard test will either exclude the man (say
he is not the biological father) or it will say he is
more likely to be the father of the tested child with
a percentage of at least 99%. Our testing protocol
will exclude at least 99% of falsely accused males.
DNA testing is the best possible means of resolving
parentage issues currently. DNA has been used in
courts in the U.S. and around the world.
Can tests be performed when the parties
involved live in different states or countries?
Yes. Memorial Blood Center can arrange sample
collection nationwide and from many foreign
countries. If an individual is having his/her sample
collected at a facility other than ours, we will send
a collection kit to the appropriate hospital or lab.
For individuals living in another country, Memorial
Blood Center will send a collection kit to the U.S.
Embassy in that country for sample collection.
If an Alleged Father is deceased can
paternity testing still be done?
Yes. DNA testing can be performed by either testing
the deceased individual’s family members or by
testing blood or tissue samples taken at the coroner’s
office during an autopsy.
How long will it take to get results?
Is the accuracy of a DNA test affected
by drug use, illness or disease?
Maximum turnaround time from the date the last
sample is received is 10 business days. Results cannot
be given over the telephone. Results are mailed to the
representative named or to the address given at the
time of sample collection. Changes in representation
or requests for additional reports must be received in
writing.
No. DNA testing is not affected by drug use, illness or
disease. DNA testing may be affected if the individual
has blood samples collected and has had either a
transfusion within 90 days of sample collection or if
the individual has had an allogeneic hematopoietic
progenitor (HPC) transplant. Buccal swab samples are
not affected.
Rev. June 2015
Parentage Testing Services
Service Fees
Effective January 1, 2008
SERVICES (Relationship Analysis — DNA Testing)
Testing Kits
FEE
No Charge
Routine Trios (Mother, Child & Alleged Father)
Buccal Cell Sample
$450.00 ($150.00/person)
Family Studies (Motherless, Fatherless, Grandparents, Siblings, Y-chromosome, etc.)
Buccal Cell Sample
$225/person
Special Testing
Umbilical Cord Blood Sample
$150.00
(must have sample from Mother)
Amniotic Fluid Sample
$150.00
Chorionic Villi Sample (CVS)
$150.00
Products of Conception
$340.00
Blood Sample from a Deceased Person
$150.00
(if part of a Routine Trio)
Blood Sample from a Deceased Person
$225.00
(if part of a Family Study)
Tissue Sample from a Deceased Person
$340.00
Twin Testing
$150.00/person
Forensic Studies
Consultation required — please call
Additional Fees
Expediting Test Results (5 business days turnaround)
$50.00/person
Immigration Shipping Fees (International Fed Ex)
$140.00 - $210.00
Expert Witness
Court Testimony
$250.00/hour plus expenses
Deposition Testimony
$200.00/hour plus expenses
Please call 612-871-6636 or 800-982-9134 with questions.
Sample collection fees are not included in the price of the testing if collected outside Memorial Blood Centers.
Prices are subject to change without notice.
Rev. June 2015
Educational Opportunities
Department of Training and Education
Volunteer Opportunities
The Training and Education Department is
committed to providing valuable, on-going education
for our staff, customers, and the community. Please
call Memorial Blood Centers and request the
appropriate department to take advantage of the
following opportunities.
Memorial Blood Centers is a volunteer-rich
community offering a vast array of volunteer
opportunities with flexible scheduling to meet
people’s interests and availability. Volunteers at
Memorial Blood Centers may deliver blood to
hospitals, staff blood drives and donor centers,
represent the blood center as Ambassadors,
or provide both administrative and special
event staffing. Volunteers provide excellent
customer service, increase Memorial Blood
Centers connections to the community, and help
save Memorial Blood Centers money. If you or
someone you know would like to volunteer or
learn more about available opportunities, please
contact Volunteer Services at 651-332-7228 or
[email protected].
Memorial Blood Centers — Central
Memorial Blood Centers — Duluth
651-332-7000
218-723-8080
American Association of Blood Banks
(AABB) Audioconferences/
American Society for Clinical Pathology
(ASCP) Teleconferences
Memorial Blood Centers — Central and Duluth
subscribe to several AABB audioconferences and
ASCP teleconferences throughout the year. Our
full-service hospitals are invited to attend at no extra
charge. Contact Hospital Services in either Central or
Duluth to receive notification of upcoming topics or
to reserve a seat.
Student Rotations
Memorial Blood Centers provides a quality blood
bank rotational experience for students in all fields of
medicine. These rotations are scheduled on a regular
basis. Dependent upon the availability of our staff, we
reserve the right to combine groups. Please contact
the Training and Education Department well in
advance of an anticipated rotation. You will be asked
to provide the number of anticipated participants and
if possible, a range of acceptable dates.
Facility Tours
Behind the scene tours of Memorial Blood Centers
facilities and laboratories are offered on a regular
basis for medical schools, as well as community
groups. School tours are routinely scheduled on
the third Tuesday of every month from 9 am to
noon. Community groups’ requests are scheduled
based on available staffing. Please call the Training
and Education Department — Central or Hospital
Services — Duluth to register a group.
Continuing Education
Memorial Blood Centers’ physicians, technologists,
and educators are available to present on a variety of
topics. Listed below are several programs currently
available through Memorial Blood Centers.
Current Topics and Controversies
in Transfusion Medicine
Memorial Blood Centers’ physicians are available
to our constituents to provide continuing education
opportunities on a variety of topics, dependent upon
current practices and/or concerns. These topics may
include, but are not limited to: Massive Transfusions,
Age of Blood, International Transfusion Practices,
Pediatric Transfusions, or Transfusion Associated
Risks. These are offered by prior arrangement only, so
please call Training and Education well in advance of
your preferred dates.
Reference Laboratory Workshops
Memorial Blood Centers’ Reference Laboratory offers
an annual workshop experience. Workshops will be
presented by Central to both the Cities’ metropolitan
area and Duluth — Northland hospitals. Topics
will vary and change every year but will be based
on hospital blood banking and interesting cases
the reference technologists have encountered from
partnering hospitals. The Reference Laboratory will
send notification when workshops are scheduled.
Rev. June 2015
Educational Opportunities • Page 59
School Presentations
Medical Advisory Council
Memorial Blood Centers’ staff members are available
at either Central or Duluth to present classroom
sessions, elementary through college-level, on several
science-based themes. Educators are encouraged
to call Training and Education to schedule these
presentations. Memorial Blood Centers’ staff will visit
the site and provide all necessary materials. A popular
presentation is “Blood 101.” This session helps young
people understand blood components and their uses,
helps them see the importance for blood transfusions,
and recognize how they can help their communities
through donating blood.
Physicians supervising the Transfusion Services
supported by Memorial Blood Centers are invited to
participate in meetings to provide input and feedback
to Memorial Blood Centers on topics related to patient
safety and product availability. These meetings will
occur once or twice a year and hospitals will be
notified when they are scheduled.
“My Blood, Your Blood”
This educational program is designed for both
elementary and secondary students. A DVD and
curriculum are provided that introduce students
to the human circulatory system. The program was
created for America’s Blood Centers by a national
team of scientists, physicians, and educators. It teaches
students the importance of our blood and blood
donation. Please call the Training and Education
Department to request this program.
Technical Advisory Meeting (TAM)
Memorial Blood Centers hosts meetings for our
customers’ blood bank supervisors or designees.
These meetings are sponsored by Central for Twin
Cities’ metropolitan area hospitals and by Duluth
for Northland affiliates. Northland meetings are
all-day events in order to accommodate out-of-town
attendees. TAMs are linked, at least twice a year, to an
AABB audioconference. Hospitals are encouraged to
submit agenda items.
Agenda items may include:
• Presentations on current topics in blood banking
• Announcements and discussions of upcoming
changes at Memorial Blood Centers
• Components
• Other related services
• Quality monitors
• Hospital-led, round table discussions
If interested but unable to attend, summary notes and
handouts are generally available upon request. Please
contact Hospital Services — Central or Duluth.
Rev. June 2015
Educational Opportunities • Page 60
Testing Services
Test Name
Test Codes
CPT Code Lab
Sample Requirements
Storage & Shipping
Requirements
Methodology & Reflex Testing
TAT
Days Set Up
ABO/Rh Typingac
MTYPE/TYPE
86900
86901
RL
5-10mL clotted blood (preferred)
5-10mL EDTA
Keep from extreme heat or cold.
Hemagglutination tube.
Verbal report in 8 hours,
written report in 5 days.2
24 hours a day,
7 days a week
Absorption3bc
ABS
86978
RL
10-20mL clotted blood and 7mL EDTA
or 14-20mL EDTA whole blood
written report in 5 days.
24 hours a day,
7 days a week
Antibody Identificationbcf
IDDN/IDDP
86900
86901
86880
86870
RL
Hemagglutination tube or Gel card. Sample may require
separation techniques. Depending on results, additional
methods such as adsorption, elution, titration may be
performed.
24 hours a day,
7 days a week
Antibody Screening bc
ABY
86850
RL
Serum or Plasma (EDTA, ACD, CPD, CPDA-1,
and CP2D) 200 μl minimum volume.
Hemagglutination tube or Gel card.
24 hours a day,
7 days a week
Antibody screening plus blood typeabc
SCR
86900
86901
86850
RL
10ml clotted blood or 5ml EDTA
Hemagglutination tube or Gel card; if positive, antibody
identification performed.
24 hours a day,
7 days a week
Crossmatch-Red Cellabc
XM
86920
86921
86922
RL
10-20 ml clotted blood and 7ml EDTA
or 14-20ml EDTA whole blood
Hemagglutination tube testing; antigen negative units
provided for patients with clinically significant antibodies.
24 hours a day,
7 days a week
DAT Battery (Direct Antiglobulin Test) cf
DAT
86880 x3
RL
5-7ml EDTA whole blood.
Hemagglutination tube testing using polyspecific, IgG, and
C3 anti-human globulin.
24 hours a day,
7 days a week
Donath-Landsteiner Test
D-L
86940
86941
RL
Contact Reference Laboratory if ordering this
test.
Hemagglutination.
24 hours a day,
7 days a week
Drug Studybc
DRUG
86975
RL
test.
Varies by drug being studied.
24 hours a day,
7 days a week
Elutionbc
ELU
86860
RL
7-10 ml EDTA whole blood.
24 hours a day,
7 days a week
HDN Evaluation, includes: ABO/Rh, DAT on cord blood,
elution on DAT positive cord blood, antibody screening and
identification on mother's blood.abc
(varies)
86900
86901
86880
86860
86850
RL
Mom: 10ml clotted blood or EDTA.
24 hours a day,
7 days a week
HLA Matched Platelet
HLA
99090
RL
product.
NA
NA
Varies.2
24 hours a day,
7 days a week
Lectin Panel (Polyagglutination test) d
PHEN
86999
RL
5-10mL clotted blood
or 7mL EDTA whole blood.
24 hours a day,
7 days a week
Kleihauer-Betkee
KB
85460
RL
5ml EDTA peripheral blood, amniotic fluid,
vaginal blood/blood smears
In-house acid elution method.
24 hours a day,
7 days a week
PLA1 Negative Platelet
PLA1
99090
RL
product.
NA
NA
Varies.2
24 hours a day,
7 days a week
Platelet Compatibility Panelh
PLCT
86022
RL
10 ml clotted blood or EDTA, less then 48
hours old.
Solid phase.
Monday-Friday
12 p.m. 1
Platelet Crossmatchh
PLXM
86022
RL
10 ml clotted blood or EDTA, less then 48
hours old.
Solid phase.
Monday-Friday
12 p.m. 1
Red Cell Phenotyping (patient antigen typing) ac
PHEN
86905
RL
Hemagglutination tube. Depending on results, may require
cell seperation and/or chemical treatment.
24 hours a day,
7 days a week
Rh Extended Phenotypingac
RH
86906
RL
Hemagglutination tube. Depending on results, may require
cell seperation and/or chemical treatment.
24 hours a day,
7 days a week
Sickle Cell Test (Hemoglobin S) g
SQ
85660
RL
5-10 ml clotted blood EDTA
Solubility Method.
24 hours a day,
7 days a week
Stroma Absorptionbc
SABSS/
SABST
86978
RL
24 hours a day,
7 days a week
Baby: 2-5ml EDTA cord blood.
Rev.
June 2013
MBC.ORG © 2013 Memorial Blood Centers. Confidential and Proprietary. All rights reserved.
Testing Services • Page 1
Test Name
Test Codes
CPT Code Lab
Sample Requirements
Storage & Shipping
Requirements
Methodology & Reflex Testing
TAT
Days Set Up
Titrationbc
TITR
86886
RL
10 ml clotted blood or EDTA
24 hours a day,
7 days a week
Transfusion Reaction Workup
(varies)
86078
86900
86901
86880
86922
86850
RL
Pre and Post Sample 10-20ml clotted blood
and EDTA.
24 hours a day,
7 days a week
Includes: ABO/Rh on pre, post and donor sample; DAT on
pre and post; antibody screening and identification on pre and
post sample, elution on DAT positive samples. Other testing as
indicated.abc
Segments from implicated donor units
Unit Antigen Screenabc
USCR
86902
RL
NA
NA
As requested.2
24 hours a day,
7 days a week
Unit Antigen Typingac
AGN
86902
RL
NA
NA
Hemagglutination tube. If unable to type historical antigen
negative, may reflex to unit antigen screening.
As requested.2
24 hours a day,
7 days a week
Unit Screening with Patient Serumbc
XSCR
RL
10-20 ml clotted blood and 7ml EDTA
or 14-20ml EDTA whole blood
Hemagglutination tube or Gel card.
24 hours a day,
7 days a week
1
This test only occurs at 12:00 PM, Monday - Friday. Please contact Reference Laboratory for STAT requests, which may incur an additional charge.
2
Ordering a test STAT may reduce turn around time. STAT requests may incur an additional charge.
3
Absorption is a reflex test performed when antibody identification reveals an autoantibody or during absorption elution testing.
Interference with Testing
Test
Reagents
a (antigen, abo)
antibodies, reagent cells
Recent transfusion, red cells coated with immunoglobulins, polyagglutination, strong cold autoantibodies, and rouleaux may interfere with testing.
b (ID, screen, XM,)
reagent panels, PEG, LISS, GEL, Alb,
High levels of serum globulins, rouleaux, hemolysis, grossly icteric samples, and grossly lipemic samples may interfere with testing. Complement binding antibodies may not be detected using plasma.
c (DAT, indirect antigen)
IgG C3 PS CC
Various drugs and certain disease states may interfere with testing.
d (polyagglutination)
Lectin panel
Bacteremia may interfere with testing.
e (K-B)
Disease states that cause retention of fetal hemoglobin or other abnormal hemoglobin's may interfere with testing.
f (DAT only)
Cold antibodies may attach to complement in clotted samples and interfere with testing.
g (SQ)
Severe anemia, persistence of fetal hemoglobin, polycythemia, multiple myeloma, cryoglobulinemia, and other dysglobulinemia may interfere with testing.
h (platelet)
ABH antibodies and isoagglutinins may interfere with testing.
Rev.
June 2013
MBC.ORG © 2015 Memorial Blood Centers. Confidential and Proprietary. All rights reserved.
Testing Services • Page 2
Thank you
We exist to serve the community.
Rev. June 2015
Thank you • Page 62
Addendum
Special Collections
Memorial Blood Centers collects and
processes the Special Collections listed in this
section. The process for ordering each type
of special collection is described below.
Autologous Collection
A collection that is intended solely for the donor.
Ordering: The ordering physician completes
and signs Physician Order For Autologous
Blood Donation (Form-DC-032).
• Fax or mail a copy of the completed order form
to MBC
• Give the original form to the donor/patient
Frequent (Dedicated)
Directed Collection
A collection that is intended for and used
solely by a single identified recipient.
Ordering: The patient’s physician contacts
a MBC physician to initiate a frequent
(dedicated) directed collection.
• After consulting with a MBC physician, if
collection is approved, the ordering physician
completes and faxes Request for Frequent
(Dedicated) Directed Donation (Form-PS-126) to
MBC.
A MBC staff member will contact the donor
to schedule an appointment.
A MBC staff member will contact the donor/patient
Therapeutic Collection
Directed Collection
Ordering: The patient’s physician completes
the Physician’s Order Form for Therapeutic
Phlebotomy (Form-DC-025).
A collection that is intended for a specific patient, but
may be crossed over for allogeneic transfusion. The
donor must meet all allogeneic donation criteria.
Ordering: The Request for Directed
Donation form is initiated by the
ordering physician (Form-DC-078).
• Fax the completed order form to MBC
• Give the original form to the donor/patient
The donor/patient must call MBC
• Complete all three sections:
◆ Section I – Ordering Physician
◆ Section II – Patient
◆ Sections III – Transfusion Service
• Fax the completed form to MBC
The donor must contact MBC to schedule an
appointment.
Note: If ABO/Rh identical units only is
marked on the order form, only donations
that are ABO and Rh identical will be
distributed to the transfusion service.
If ABO/Rh identical units only is not marked, all
compatible collections will be distributed to the
transfusion service.
Added: August 2011
Rev. June 2015
Addendum • Page 63

Hospital Resource Guide - Memorial Blood Centers

Transcription

Similar documents

Perry`s Memorial.indd

Read Dunning Memorial Park - Wolff Landscape Architecture

Attached File

4518 Mem Hwy Broch.pub

Newsletter - Apartments In Little Rock

2701 Memorial Hwy brochure

Memorial to the Missing Fountains

Plasma Thawer - kizlonmedical.com

Chapter Six UNIQUE PEOPLE

Blood Blood transports substances and maintains homeostasis in